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GENERAL INTRODUCTION 
Introduction 
The separation of biomolecules such as proteins, carbohydrates and 
lipids has classically depended upon differences in their physio-
chemical properties (1,2,3). Examples of such properties are solu­
bility of the biomolecules in salt solutions and organic solvents, 
density, size, and the charge-to-mass ratio of the biomolecule (3). 
Techniques based on these properties include the various precipitation 
schemes, gel permeation chromatography (GPC), ultrafiltration, electro­
phoresis and centrifugation (3). 
The gross separation of these general classes of biomolecules is 
relatively simple since they are quite different in their physio-
chemical characteristics (1). Typically, single contact techniques 
such as precipitation or liquid extraction are capable of selecting the 
desired family of biomolecules (3). Within a class, however, physio-
chemical differences are much smaller, requiring more rigorous schemes 
to separate the desired components (3). Usually biochemists have 
approached these situations with multi-dimensional separation schemes 
involving a variety of mechanisms (2). One disadvantage of this multi­
dimensional approach is that it still requires fairly significant 
differences between physiochemical properties of the desired bio­
molecules and the other molecules of the matrix (3). Since such 
differences may not be present, these techniques are not always suit­
able for the separation of very similar biomolecules. 
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An alternate approach is the use of a single separation mechanism 
in a multiple contact process such as high performance liquid chroma­
tography (HPLC) (1,4,5). In addition to the hydrophobic separation 
mechanisms usually considered, ion-exchange, surface adsorption, size 
exclusion and mixed mode retention mechanisms are available. These 
various retention mechanisms allow the application of these single 
mechanism separations to a wide variety of bioanalytical separations. 
An example of the selectivity possible with this process is the ability 
to resolve peptides differing by only one amino acid (6). Unfortu­
nately, in the majority of cases a multi-dimensional pre-separation 
must first be performed to narrow the range of components in the sample 
and to simplify optimization of the separation for the analyte (6,7) . 
Such schemes can be tedious and low in sample recovery (2,6,7) . 
A more selective separation mechanism would simplify biochemical 
analysis. Biological recognition, or the innate ability of bio-
molecules to form specific non-covalent complexes with other molecules, 
is one of the most selective processes known (3). Examples of this 
type of interaction include antigen-antibody interactions, nucleic acid 
interactions, lectin-carbohydrate interactions, and enzyme-substrate 
interactions (2,3). The use of biological recognition as an analytical 
tool for the quantitation of biomolecules is an accepted practice. 
Examples of methods based on bioactivity are the various enzyme (8) and 
immunological assays (9). Typically, these procedures rely on the high 
selectivity of the bioreagent to bind with the analyte in the sample 
without a prior separation. Unfortunately, these techniques still 
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require that the product of the biorecognition reaction be differen­
tiated from the sample matrix in some manner. This is required so that 
the extent of the biorecognition reaction can be measured without a 
separation. An exançle of this differentiation is the formation of a 
uniquely colored product as a result of the enzyme reaction. This 
requirement limits the broad application of biorecognition techniques 
to the relatively few biomolecules in which nature has fortuitously 
provided such a feature. 
To overcome this problem, a more versatile approach is required. 
The coupling of a selective separation technique based on bioactivity 
with a general detection method such as UV absorbance has proven quite 
useful. Examples of this combination of selective separation and 
universal detection are affinity chromatography, affinity electro­
phoresis, and affinity ultrafiltration (2). The term "affinity" is 
used with these techniques to designate that bioactivity is the basis 
of the separation mechanism (10). As with any separation method, these 
techniques depend upon the partitioning of the analyte between two 
phases with the relative enrichment of the analyte in one of the phases 
(3). In these methods, the bioreagent, referred to as the affinity 
ligand, is fixed in one of the phases. The analyte is then applied and 
allowed to partition between the phases. The analyte is preferen­
tially taken up in the ligand phase by virtue of the formation of the 
affinity complex. This permits the very selective separation of the 
analyte from the sample and the quantitation of the analyte with a 
nonspecific technique. 
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Principles and practice of affinity chromatography 
Of the various techniques based on biorecognition, the differ­
ential migration processes, specifically affinity chromatography, have 
been the most popular. The general scheme of an affinity chromato­
graphic separation is presented in Figure 1. In this scheme, the 
affinity ligand is covalently bound to the stationary phase and a 
multi-component sample containing the analyte is applied to the column 
under conditions favoring the formation of the analyte-ligand complex. 
As this sample flows through the column bed, the affinity ligands bind 
with the analyte. The nonretained components then elute from the 
column at the void volume. After the nonretained components have been 
washed from the column, the eluent conditions are changed so that the 
analyte-ligand complex dissociates and the analyte elutes from the 
column. As so described, all affinity chromatograms are fundamentally 
similar. An initial band containing the nonretained components elutes 
at the column void volume and is followed by the analyte band eluted as 
the strong eluent is applied to the column. 
The initial step in the development of an affinity chromatographic 
technique is the selection of an appropriate affinity ligand. This is 
usually dictated by the bioactivity of the analyte. The possible 
candidates for an affinity ligand are limited to the relatively few 
molecules capable of forming noncovalent complexes with the analyte. 
Once the possible ligands have been selected, the characteristics of 
the analyte-ligand complex as well as the cost, availability and 
stability of the proposed affinity ligand must be considered (2). 
Figure 1. Separation scheme for affinity chromatography with 
biospecific elution 
Adsorb ^ 
/ 
Regenerate 
Elute 
y 
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Examples of commonly used affinity ligands are enzyme cofactors and 
inhibitors, sugars, proteins and nucleic acids. 
Affinity ligands can usually be divided into two types: general 
and specific (2,11). The general ligands exhibit an affinity for an 
entire class of biomolecules. Examples of these ligands include enzyme 
cofactors, such as NAD, and lectins, such as Concanavallin A. 
Synthetic dyes have proven useful as general ligands with some analytes 
(12). These general ligands retain all components of the sample with 
an affinity for the ligand and will coelute these components. The 
second type, the specific affinity ligands, exhibit an affinity for a 
single analyte molecule, eluting the analyte in a highly purified form 
(13,14). Good examples of such specific affinity ligands are anti­
bodies. These are immunoglobulin (Ig) proteins produced by many 
animals in response to the presence of a foreign species, or antigen. 
These Ig proteins are capable of complexing the antigen to which they 
were prepared to facilitate the removal of the antigen from the body. 
As such, these Ig proteins can be used as affinity ligands for many 
analytes for which suitable affinity ligands are not available (13-15). 
After the affinity ligand has been selected, the next step is to 
choose the support to be used. Several criteria for an affinity 
support have been described (2,16). As with any chromatographic 
support, the mechanical rigidity must be sufficient to withstand the 
eluent pressure and flow requirements. The support should also be 
inert, with the affinity interaction being the only retention mechanism 
operating in the column. To meet this requirement, nonionic and 
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hydrophilio materials with sufficient pore size to minimize size 
exclusion phenomena are used. It must be possible to "activate" this 
support so that the affinity ligand may be immobilized on it. 
The chromatographic efficiency required by the separation must 
also be considered. Generally, the specificity of the retention 
mechanism is sufficient so that resolution is not a problem. Rather, 
the efficiency is required to obtain the desired separation speed and 
band volume. Preparative techniques require high sample loadings, but 
speed and bandwidth may be compromised to permit the use of a less 
costly support material in a "low performance" chromatographic 
technique. These requirements are met with polysaccharide supports. 
Exan^les of such supports are cellulose, dextran and agarose, which 
have typically been used in preparative affinity chromatography 
techniques (2,13). 
In some experimental situations, greater chromatographic effi­
ciency and speed are required than can be provided with these low 
performance supports (17). To meet these requirements, dual 
composition supports have been prepared. These supports are a 
combination of two phases, one providing mechanical rigidity and the 
other minimizing nonspecific adsorption and providing sites for the 
attachment of affinity ligands. Silica supports have been modified to 
meet these criteria (18). These materials are made nonadsorptive by 
forming a covalently bound hydrophilic coating over the silica base. 
To form this coating, the silica surface is first derivatized with 
glycidoxypropyltrimethoxysilane (GOPS) and the epoxy group opened to 
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form a glycerol layer over the silica. This glycerol layer is similar 
to the polysaccharide materials with respect to reactivity and 
adsorptive characteristics. Typically, these supports have been used 
for analytical studies and mechanistic studies of the affinity 
chromatographic process (17,19,20) where the separation efficiency must 
be high. 
The third step in the design of an affinity separation is the 
immobilization of affinity ligands onto the solid support (2,17). The 
most common immobilization chemistries use an activation reagent to 
couple an amine group from the ligand to a hydroxyl group of the solid 
support. The cyanogen bromide activation of the support linking the 
ligand through an isourea group has been the most popular technique 
(11,17). However, this group is relatively unstable, allowing ligand 
to "leak" from the support. Also, the isourea group is charged and 
introduces an ionic site to the support and, thus, the possibility of a 
nonspecific retention mechanism (2,11). To overcome these problems, 
several alternatives to the cyanogen bromide method have been 
developed. Some of these immobilization reagents are 1,1'-carbonyl-
diimidazole (GDI) (21), tresyl chloride (22), and Schiff's base inter­
mediate (23). In each case the covalent bond formed between ligand and 
support is stable, retaining the ligand on the support and presenting 
minimal nonspecific adsorption problems. Generally, the activation of 
a support with any of these methods is a simple procedure. 
The availability of these various immobilization chemistries is 
important. The immobilization method used can have a dramatic effect 
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on the activity of the affinity ligand. For example, the activity of 
immobilized Protein A has been observed to vary greatly with the 
immobilization chemistry (24,25). At present this effect is not well 
understood. This requires that the optimum immobilization method for 
an affinity ligand be determined empirically. 
Once the immobilization chemistry has been chosen and the affinity 
support prepared, the support can then be packed in a suitable column 
and prepared for use. This requires the determination of proper sample 
application and elution conditions. The sample must be applied to the 
column under eluent conditions favoring the formation of the affinity 
complex. This requires that the eluent pH and ionic strength be proper 
to maintain activity of the analyte and ligand and that any cofactors 
needed for activity be included in the eluent. Finally, the chromato-
graph must be operated so that sufficient time is permitted for the 
affinity interaction to occur (24). 
Two general schemes have been developed for elution of the analyte 
from the column (2,17). The use of a denaturing reagent in the eluent 
to disrupt the affinity complex and elute the analyte is the most 
common elution technique (2,14). Examples of denaturing eluents are 
low pH buffers, chaotropic salt solutions and organic solvents. In 
using these eluents care must be taken not to irreversibly denature the 
affinity ligand (14). Biospecific elution is the second general 
elution technique. In this case, illustrated in Figure 1, a second 
biomolecule having an affinity for either the affinity ligand or 
analyte is added to the eluent. This second biomolecule is referred to 
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as the inhibitor. As this eluent is applied to the column, a complex 
equilibrium is established as both the analyte and inhibitor compete 
for available affinity ligand sites (19,20,26). With this situation, 
the analyte is displaced from the stationary phase and eluted from the 
column. Limitations of this type of elution include the lack of 
availability of a suitable inhibitor for many affinity systems and 
isolation and detection problems caused by coelution of the analyte and 
inhibitor (2). 
History and development of affinity chromatography 
One of the first reports of an affinity chromatographic separation 
was the purification of a-amylase (27) This work:, in which insoluble 
starch served as both the affinity ligand and the solid support, was 
reported by Starkenstein in 1910. The first rationally designed 
affinity chromatographic separation was reported in 1951 by Campbell et 
al. (28). In this work, antibody was recovered from blood serum with 
an immobilized antigen column. The affinity support was prepared 
specifically for this work by covalently bonding the antigen ligand to 
the cellulose matrix. 
In 1953 the concepts and application of affinity chromatographic 
procedures were extended by Lerman (29). He proposed the use of both 
specific affinity ligands, such as antigens, antibodies, enzyme 
substrates or enzyme cofactors, and general affinity ligands, such as 
azo-dyes. Additionally, he proposed the use of both biospecific 
elution and nonspecific elution techniques to recover analyte from the 
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column. Unfortunately, the cellulose supports available at the time 
had poor chromatographic properties. Also, the ligand immobilization 
chemistry was not sufficiently developed (2) to permit the simple 
covalent attachment of a wide range of ligands while maintaining the 
inert nature of the support. 
The development of beaded agarose supports for GPC (30) and the 
introduction of the cyanogen bromide immobilization method (31) during 
the mid-1960s overcame most of the experimental limitations. In 1968 
Cuatrecasas used these advances to produce methods for the affinity 
chromatographic preparation of staphyloccal nuclease, a-chymotrypsin, 
and carbbxypeptidase from their respective biological sources (16). 
Also in this study he proposed the term "affinity chromatography" to 
describe this technique. This report marked the advent of the modern 
era of affinity chromatographic separations. By 1971 over 100 applica­
tions of the technique had been reported, most using the technique as a 
preparative tool. 
The first text devoted to affinity chromatographic techniques was 
written by Dean and Lowe and appeared in 1974 (32). As the scope of 
the field enlarged, several variations of the technique developed and 
nomenclature soon became troublesome. To address this problem, a 
section of the 1975 Enzyme Engineering Conference suggested that the 
general term "affinity chromatography" be used to describe the 
technique (10). Interest in affinity chromatography continues today 
with several suppliers offering ready-to-use affinity supports for a 
number of applications. 
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The purification of biochemicals remains the most common applica­
tion of affinity chromatography at present. Using affinity chromatog­
raphy, dramatic purifications of biochemicals have been reported with 
relatively simple experimental procedures. In addition to preparative 
uses, affinity chromatography has also been used to quantify analytes 
from biological matrices. Glycosylated hemoglobin in serum (11), 
proteins in urine (17), and IgG in serum (33) have been determined with 
affinity techniques. These applications are characterized by minimal 
sait^)le preparation prior to chromatographic analysis and relatively 
clean chromatograms. A variation of these uses is an affinity-based 
sample preparation where both removal of sample components and concen­
tration of the analyte are possible. An example of this type has been 
described for the determination of aflatoxins (34) . An antibody 
specific for aflatoxins B(l) and B(2) was prepared and immobilized. 
This affinity support was then packed in a short column. With this 
type of column a large sample volume may be applied and eluted in a 
small volume of strong eluent, in this example, methanol. The analyte, 
once recovered, is then assayed with the standard protocol for 
aflatoxins. The affinity pre-separation resulted in cleaner 
chromatograms as well as enhanced sample recovery and limit of 
detection for aflatoxin. 
The development of high performance supports has produced dramatic 
advances in liquid chromatographic techniques in the last two decades. 
The improvements in chromatographic speed and efficiency have resulted 
in better resolution of analyte from sample components and enhanced 
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sensitivity of detection with shorter analysis times. Additionally, 
these techniques have proven to be easily automated with small 
computers, greatly simplifying chromatographic analysis. 
The application of these high performance supports to affinity 
chromatography was limited by the adsorptivity of these supports. The 
development of glycidoxypropyltrimethoxysilane derlvatization of silica 
supports by Regnier to produce a nonadsorptive hydroxyl surface for 
size exclusion chromatography ameliorated the nonspecific adsorption 
problem (18). The initial report of the combination of an affinity-
based separation with HPLC equipment was by Ohlson in 1978 (35). In 
this work, horse liver alcohol dehydrogenase and soybean trypsin 
inhibitor were separated from the respective sample matrix with 
analysis times under five minutes. 
To designate this combination of affinity separation mechanism and 
HPLC equipment, the term High Performance Affinity Chromatography 
(HPAC) has been used (36). Applications of HPAC have been described 
for the determination of both albumin and immunoglobulin G in human 
serum (33). This work demonstrated the analytical application of very 
short columns (less than one cm) for HPAC separations based on the 
tremendous selectivity of the affinity mechanism (36). HPAC has also 
been used for the fundamental study of biochemical interactions 
(19,24,37,38). The improved chromatographic efficiency of HPAC 
compared to regular affinity chromatography has allowed the chromato­
graphic estimation of kinetic as well as thermodynamic parameters, 
which had not been possible with the low performance supports (19). 
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As currently developed, affinity chromatographic techniques have 
been applied to many aspects of biochemistry. The preparative use of 
affinity chromatography remains the most commonly encountered form of 
the technique. Although fundamentally similar, analytical applications 
generally require the use of high performance supports. The analytical 
applications allow for more rigorous elution than is possible with 
preparative applications since the retention of activity by the analyte 
is not important. Limiting this is the need to maintain the activity 
of the affinity ligand. Antibody ligands are excellent candidates for 
this type of elution as they can be successfully renatured many times 
(39). In addition, affinity chromatography can be used for the study 
of fundamental biochemical interactions. Here the unique properties of 
the chromatographic approach may simplify the design of the desired 
experiment (37). 
The Protein A-Immunoglobulin affinity interaction 
Protein A is a bacterial cell wall protein isolated from 
Staphylococcal aureas (40). This protein is capable of forming non-
covalent affinity complexes with many immunoglobulin proteins (40,41). 
The unique properties of both Protein A and the immunoglobulins have 
generated much interest in the use of these proteins as analytical (33) 
and preparative reagents (42). Examples of applications involving 
these proteins include such diverse areas as preparative chromato­
graphic techniques (43) and immunoassay techniques (44-46). The 
following is a brief description of both Protein A and the immuno-
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globulins and the resulting affinity complex formed between these 
proteins. 
Protein A is found in many strains of the staphylococcus bacter­
ium, although the Cowen I strain has been the most commonly used source 
(45). The coverage of Protein A on the cell surface of the bacterium 
has been estimated to be 80,000 molecules Protein A per cell (47). 
Assuming a bacterial cell diameter of two micrometers, or a surface 
area of 3.1 square micrometers per cell, this represents 25,700 Protein 
A molecules per square micrometer. Protein A is recovered from S. 
aureus with a heat extraction process and purified with size exclusion 
and ion exchange chromatography (40). Protein A is a very rugged 
molecule capable of retaining activity through treatments as extreme as 
pH 2, urea, thiocyanate, guanidinium HCl, heat and aqueous ethylene 
glycol (48). 
Protein A has a molecular weight of 42 kD, an isoelectric point of 
5.1 (49), and a diffusion coefficient of 4.3 x 10"? cm^/sec. The 
hydrodynamic data are a Svedberg constant of 2.1 S, a Stokes radius of 
5.0 nm, and a specific volume of 29 mL/g. These values are indicative 
of a larger protein than indicated by the molecular weight (50). 
Protein A is also known to have an f/f^in ratio of 2.1, indicating an 
extended or rodlike shape, which would explain the apparently anomalous 
data regarding molecular size (51). 
The structure of Protein A is composed of five subunits arranged 
in a linear fashion. The C terminal subunit is a cell wall anchoring 
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unit and the four remaining subunits are approximately homologous and 
are each capable of complexing or binding one immunoglobulin molecule 
(52). The intact protein molecule, however, binds less than the 
optimal four immunoglobulin molecules. This reduced binding capacity 
is probably due to steric hindrance (53). 
The immunoglobulin (Ig) proteins or antibodies are produced by the 
humoral immune systems of many animals in response to the presence of a 
foreign species and are responsible for eliminating foreign species 
from the body. Examples of the foreign bodies (or antigens) which can 
initiate the production of antibodies are peptides and proteins from 
phylogenetically different organisms. 
The ability of modern immunization techniques to prompt the immune 
system to produce a protein capable of specifically binding another 
molecule is a valuable tool. This type of methodology potentially 
allows for the custom biosynthesis of a bioreagent for virtually any 
analyte of a biological origin. Once a sufficient quantity of analyte 
(usually a few milligrams) has been prepared, it is possible to induce 
antibody production. With this approach, the analyte becomes the 
antigen responsible for inducing the production of the antibody. 
Macromolecular analytes are naturally antigenic. Smaller analytes may 
be made antigenic through coupling with a naturally antigenic carrier 
molecule. As antibodies bind to only a small region, or epitope, of 
the antigen, some of the antibodies induced by this hybrid antigen will 
be capable of binding the native analyte. The immune system will 
prepare several unique antibodies against a single antigen. This is 
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referred to as the avidity of the antibody and such preparations are 
referred to as polyclonal (54). By using current cell culture 
techniques, it is possible to select for the production of just one of 
these immunoglobulins, allowing for more homogeneous properties of the 
antibody reagent (55). Mammals may produce up to five general classes 
of immunoglobulins: IgG, IgA, IgM, IgD and IgE (41). Of these, IgG is 
the most often produced and used as an antibody reagent (41). 
The physiochemical properties of the IgG immunoglobulin class have 
been reported. These include a molecular weight of about 153 kD, a 
diffusion constant of approximately 4 x 10"? cm^/sec, a Svedberg 
constant of 6.6 to 7.2 S, an intrinsic viscosity of approximately 0.06, 
a partial specific volume of about 0.739 mL/g, an f/f^in ratio of about 
1.38 and an isoelectric point between 5.8 and 7.3 (56). These values 
are characteristic of a large globular protein (50). The wide range of 
isoelectric points and other physiochemical properties given is 
indicative of the heterogeneity of the primary structure of these 
proteins. This heterogeneity arises from small regions of the Ig 
molecule which are variable in their amino acid sequence, allowing for 
the production of antibodies capable of binding to a wide variety of 
different antigens. 
Structurally, the IgG molecule can be divided into three major 
regions. Two of these are the Fab regions, where the actual antigen 
binding occurs. Both of these regions are identical, and the native 
antibody is bivalent with respect to antigen binding. The actual 
binding occurs at the amino terminal end of the Fab regions where the 
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amino acid sequences of each individual type of antibody are variable 
(54). The third region of the IgG protein is the Fc region; this 
region is the home of the site which interacts with the complement 
system to effect removal of the antigen from the body. The Pc region 
is also where Protein A binds with the immunoglobulin protein (52). 
The interaction of Protein A and immunoglobulin proteins to form a 
noncovalently bound complex has been widely studied. Protein A was 
initially reported to bind exclusively with IgG (43), but further 
studies have demonstrated that it also binds with various mammalian and 
avian IgM (57), IgA (58) and IgE (59) proteins. Often a species may 
exhibit distinct types or subclasses of each of these immunoglobulin 
proteins through variations in the Fc region which can affect the 
formation of Protein A-IgG. In humans four such IgG subclasses have 
been demonstrated (54). Of these, IgG3 is the only one which does not 
complex with Protein A (41,43,60). This subclass represents only seven 
to ten percent of the total amount of human IgG protein (60). Rabbit 
IgG has not been shown to demonstrate such subclass variation with 
Protein A binding (41). This makes rabbit IgG a good selection for 
fundamental studies of the Protein A-IgG interaction (24,37). Regard­
less of the type of immunoglobulin protein used to complex with the 
Protein A, the complex forms readily in solutions of pH 7-7.4 and 
dissociates readily in an acidic solution (40,41,43). However, the pH 
at which dissociation occurs tends to be unique to each immunoglobulin. 
This has been used to separate subclasses of human IgG and guinea pig 
IgG with a pH gradient (60,61). Dissociation of the Protein A-IgG 
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complex is also possible with urea, guandinium HCl, high molarity 
neutral salts, ethylene glycol and lithium diiodosalicylate (55). 
The formation of the Protein A-IgG complex at neutral pH values 
is highly favored. Affinity or equilibrium constants (Kgq) of this 
reaction have been variously reported to be 3 x 10® to 1 x 10^® M~^ 
(55). Experimental observations have indicated that the intact Protein 
A molecule is bivalent with respect to IgG (53). The affinity constant 
for each of the two IgG binding sites has been reported as 2.3 x 10® M"^ 
and 6.4 x 10® M~^ (62). This difference in Kgg for the two sites 
demonstrates a negative cooperativity in the binding of IgG to Protein 
A. The overall Kgg for both adsorption steps has been determined 
experimentally as 4.1 x 10® (62). 
The kinetics of the association process have been studied. 
Usually, such studies involve the complexation of immobilized Protein A 
with radioactively labeled IgG. A study of the association of IgG onto 
killed S. aureau bacteria with an excess of active Protein A on the 
cell surface has reported very fast initial binding of 74 and 81% of 
initially free IgG at 10 and 30 sec, respectively. Maximum uptake was 
attained in two minutes (45). Similar data have been obtained for IgG 
covalently bound to paper disc and Protein A adsorbing from solution. 
At an excess of IgG ligand sites, the adsorption was found to be 
greater than 90% complete in three minutes, with a maximum yield 
attained in 15 minutes (62). In such experiments, as smaller excesses 
of ligand are used, the time required for equilibration increases to 
several hours (62). Conversely, the adsorption of IgG by immobilized 
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Protein A in an affinity chromatographic configuration has been 
observed to be rapid, probably due to the large excess of ligand used 
with this technique (63). 
When sufficient IgG is used to saturate the Protein A column, 
incomplete adsorption of IgG results. Incomplete adsorption has also 
been observed when high eluent flow rates are used even with an excess 
of ligand (24,38). In this phenomenon an injection of pure analyte 
results in two peaks, one that is retained on the column and one that 
is not. It has been shown that this is a kinetic adsorption problem, 
or that the column residence time was too short for all of the applied 
IgG to interact with the ligands on the column. It has also been shown 
that the relative size of the retained fraction is proportional to the 
residence time and that this relationshp can be used to study the 
adsorption kinetics of the system. Using this approach, known as 
"split-peak" chromatography, the association rate for the binding of 
rabbit IgG to Protein A has been estimated as 2.4 x 10® sec"^ (24). 
The dissociation of the Protein A-IgG complex has been similarly 
studied using killed Staphylococcus a bacteria. In this study. Protein 
A sites on the bacterium were saturated with labeled IgG and the 
progress of the dissociation of the affinity complex was followed as 
label was lost from the bacteria. In neutral pH solutions, at 
equlibrium less than five percent of the IgG was in solution at 90 
minutes afL 37°C (44). In another set of studies, the same workers 
found the complex dissociation rate to be 4.8 x 10"^ sec"^, thus 
demonstrating the dynamic nature of the Protein A-IgG complex. It has 
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also been shown that when an acidic solution (pH 5) is applied to the 
complex, 75% of the bound IgG is dissociated in one hour. This 
demonstrates the ability of acidic conditions to dissociate the Protein 
A-IgG complex. The bioselective dissociation of IgG has been similarly 
studied. The presence of free solution IgG, in excess, has been shown 
to result in the dissociation of 85% of bound labeled IgG in one hour 
(43). In this situation, once a dissociation of labeled ligand occurs, 
mass action favors the adsorption of unlabeled IgG over the readsorp-
tion of labeled IgG. These results indicate that the stability of the 
coitçlex is at least partially due to the rapid readsorption of 
dissociated IgG onto the Protein A ligand. 
Outling of the Experimental Sections 
The main goal of this work is to study the .application and optimi­
zation of HPAC techniques. Both experimental and theoretical aspects 
of the design of an affinity separation will be examined with respect 
to the use of protein affinity ligands. Immobilized Protein A is used 
throughout the work as an example of such a macromolecular affinity 
ligand. The Protein A-IgG affinity interaction has been previously 
proposed as a model system for the study of protein-protein non-
covalent complex formation (24,37,48) and is used here to demonstrate 
the suitability of HPAC for use with macromolecular ligands and 
analytes. 
The application of HPAC techniques to the analysis of biological 
samples would combine the selectivity of the bioactivity methods with 
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the simple, direct quantitation offered by spectrophotometry. The 
affinity separation mechanism promises a minimum of preseparation 
sample preparation coupled with the simplicity of an HPLC apparatus, 
eliminating many manipulations and permitting shorter analysis times. 
An example of one HPAC quantitative method is given in Section I, where 
the IgG protein is separated from a human serum matrix with an 
immobilized Protein A ligand. 
The preparation and properties of immobilized protein ligands in 
high performance affinity chromatography is an important aspect of the 
development of any HPAC separation. A few of the various immobiliza­
tion chemistries are presented in Section II with emphasis on the use 
of l,l'-carbonyldiimidazole (GDI) for the covalent attachment of 
protein ligands to diol-bonded silica suppports. Experimental condi­
tions for the optimal yield of several immobilized protein ligands are 
also described. Additionally, the ability to control the yield of 
protein immobilization so that an affinity support can have defined 
characteristics is demonstrated. The effect of immobilization condi­
tions on the properties of the resulting immobilized protein were also 
examined. 
The kinetics of analyte dissociation from an affinity support are 
an important characteristic of an affinity separation (17). The 
conplex must be sufficiently stable to be retained on the support while 
capable of being eluted in some manner. Thus, not only are the 
kinetics of the native dissociation processes important, the kinetics 
of the denaturing dissociation processes are similarly important 
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(44,45). The Peak Decay (PD) model is a special case of the more 
general affinity chromatographic models and was designed specifically 
for the study of biocomplex dissociation processes (37). The PD model 
is designed to negate any readsorption of the analyte once dissociation 
has occurred so that the elution is strictly a function of the affinity 
complex dissociation. This model is amenable to the study of both the 
maturing and denaturing dissociation processes, and has been success­
fully applied to the study of the Con-A sugar interaction (64). The 
application of the PD model to the study of the Protein A-IgG inter­
action is described in Section III and the kinetic parameters of both 
biospecific and low pH elution are reported for this affinity system. 
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SECTION I. 
DETERMINATION OF IMMUNOGLOBULINS IN 
BLOOD SERUM BY HIGH PERFORMANCE 
AFFINITY CHROMATOGRAPHY 
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SUMMARY 
High performance affinity chromatography columns were prepared by 
immobilizing Protein A from Staphylococcus aureus on 10 um diol-bonded 
silica. Immunoglobulin-containing samples were injected into the 
column at pH 7 and the nonretained components eluted. The retained 
immunoglobulins were then eluted by a step change to pH 3. The 
retention characteristics of the Protein A column were studied with the 
chromatography of immunoglobulin G, A, and M standards as well as 
electrophoresis and Ouchterlony double diffusion immunoassay of both 
retained and nonretained serum fractions. Retention of IgGl, IgG2 and 
some IgA was shown. IgM, some IgA and albumin were not retained 
indicating that nonspecific adsorption was not a significant problem. 
Analysis of 3 UL samples of reference blood sera without pretreatment 
was performed using immunoglobulin G standards. Good agreement was 
observed between the immunoglobulin G concentrations measured by this 
method and by radial immunodiffusion. Chromatographic analysis times 
were 4 min or less. 
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INTRODUCTION 
High performance affinity chromatography (HPAC) is potentially 
useful for the analysis of complex samples such as biological fluids 
with a minimum of sample pretreatment. Relatively nonspecific 
detection methods, such as UV absorbance, can be used if the 
selectivity of the affinity chromatography column is sufficient. 
One application of clinical interest is the determination of 
immunoglobulins in blood serum. There are five known classes of 
immunoglobulins: immunoglobulin G, A, M, D and E (IgG, IgA, IgM, 
IgD, IgE). Of these five, only the first three are usually found in 
significant concentrations in blood serum (Table I). The concentra­
tions of the immunoglobulins are altered by many diseases (1). Common 
methods for measuring immunoglobulins include electrophoresis, radial 
immunodiffusion (RID), Immunoelectrophoresis, nephelometry and radio­
immunoassay (1-3). HPAC methods for quantitating immunoglobulins 
should be inexpensive, since the immobilized ligand is reused, as well 
as simple and rapid. 
Immobilized antibodies specific for certain classes or subclasses 
of the immunoglobulins could be used as the affinity ligand for HPAC 
determinations. We have chosen to immobilize a more general ligand. 
Protein A from Staphylococcus aureus, for the determination. Protein A 
is known to bind with the Fc region of IgGl, IgG2 and IgG4 (4,5). 
IgG3, a subclass which normally constitutes 7-9% of the total IgG 
(6,7), does not react with Protein A (4-6). The subclasses of IgG have 
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Table I. Immunoglobulin concentrations in blood serum 
Immunoglobulin Molecular weight Normal concentration (mg/mL) 
IgG 150,000 7.1-15.3 
IgA 160,000 0.6- 4.9 
IgM 900,000 0.4- 2.1 
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been partially separated by Protein A affinity chromatography using a 
pH gradient (6). It initially was believed that Protein A only bound 
to IgG (5)/ but more recent studies have shown that it also binds to at 
least some subclasses of IgA (4,8), IgM (8,9) and IgE (10). 
Table I lists the concentrations of several immunoglobulins in 
blood serum (2). Since Protein A binds to most of these immuno­
globulins, immobilized Protein A should be useful for the determination 
of the immunoglobulin content of blood serum. Immunoglobulins retained 
by the Protein A ligand can be eluted by a change in buffer from 
neutral to acidic pH (5,6,9). 
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EXPERIMENTAL 
Reagents 
Antihuman IgA, antihuman IgM and antihuman serum albumin antisera 
as well as Protein A, human serum albumin (HSA) and human immuno­
globulin G were obtained from Sigma (St. Louis, MO). Agarose was from 
Bio-Rad (Richmond, CA). Reference blood sera were obtained from Hyland 
(Deerfield, IL). Human immunoglobulin A (98%) and human polyclonal 
immunoglobulin M (98%) came from Calbiochem-Behring (San Diego, CA). 
HPLC-grade phosphoric acid, 85%, was obtained from Fisher (St. Louis, 
MO). Antiserum to human IgGl, IgG2, IgG3, and IgG4 were from Miles 
Laboratories (Elkhart, IN). 
Apparatus 
The chromatographic system was described previously (11). A Bio-
Rad 1420B power supply and 155 tube gel cell were used for electro­
phoresis. 
Methods 
LiChrospher SI4000 diol-bonded silica was synthesized and 
activated with l,l'-carbonyldiimidazole as described previously (11) 
with the following modification: 0.050 mL (3-glycidoxypropyl)tri-
methoxysilane were used per gram of silica. 
Activated silica (0.6 g) was shaken at 4^0 with 1,1 mg Protein A 
in 50.0 mL 0.1 M sodium phosphate buffer, pH 8.0. After 24 h, 33 uL 
ethanolamine were added and the mixture shaken for an additional 24 h 
to remove any remaining active groups. The immobilized Protein A was 
31 
washed with 2 M NaCl and water and then was slurry-packed into a 5.0 cm 
X 4.6 mm i.d. column at 2700 psi using 0.1 M potassium phosphate 
buffer, pH 7.0. 
Chromatography was performed at room temperature. Reference 
blood sera were injected without pretreatment using 3 UL or 10 UL 
sample loops. Immunoglobulin G standards were prepared in the pH 7.0 
buffer described below. The weak mobile phase was 0.1 M potassium 
phosphate buffer, pH 7.0, prepared using HPLC-grade H3PO4 and reagent 
grade KOH. The strong mobile phase was 0.1 M potassium phosphate, pH 
3.0, prepared using reagent grade KH2PO4 and KOH. Detection was by UV 
absorbance at 280 nm. All separations were performed at a flow rate of 
1.0 mL/min. Sangles were injected into the pH 7.0 mobile phase. 
Retained proteins were eluted by a step change to the pH 3.0 buffer. 
Retained and nonretained peaks were collected from repeated 
injections and concentrated using an Amicon 12 ultrafiltration chamber 
and PM 30 membranes (Lexington, MA). The concentrated fractions were 
resuspended in pH 7.0 buffer and concentrated a second time. Samples 
of the concentrated fractions (20-100 were examined by electro­
phoresis and qualitative immunoassay studies. 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) was performed using 7% discontinuous gels at pH 8.9 according to 
a published procedure (12) which was modified to include 0.1% SDS in 
solution #1 and the electrode buffer solution. Gel tubes of 10 cm x 5 
mm i.d. were used. The gels were stained with Coomassie Brilliant Blue 
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R-250 (Eastman Kodak, Rochester, NY). Bovine serum albumin, IgG, IgA 
and conjugated BSA molecular weight standards (66,000-264,OOOD) (all 
from Sigma) were used as reference standards. 
The immunological characterization of the fractions was performed 
by the method of Ouchterlony double diffusion (13). To improve 
adhesion of the agarose gel, the slides were pre-coated with 0.1% 
agarose and dried. A 1% agarose solution made up in 0.1 M phosphate, 
pH 7, and 0.9% sodium chloride was applied to a depth of 2 mm over 
these slides and allowed to set. A circular pattern of six wells about 
a central well was chosen. Both retained and nonretained fractions 
were assayed for the presence of IgGl, IgG2, IgGS, IgG4, IgM, IgA and 
HSA. Aliquots of the eluent fractions (20-200 uL) were placed in the 
central well with the various antisera in the perimeter wells. The 
gels were placed in a humidity chamber where the diffusion process and 
precipitation reaction were allowed to progress for four to six days. 
The gels were washed three times with 0.9% sodium chloride to remove 
nonprecipitated proteins. The precipitated proteins were stained with 
Coomassie Brilliant Blue and the gels preserved by drying. 
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RESULTS AND DISCUSSION 
To utilize Protein A for clinical analysis, it clearly is 
important to know its specificity of binding. We examined this by 
testing the retention of several immunoglobulin classes on our HPAC 
columns with fractions collected for qualitative electrophoretic and 
immunological study. 
Figure 1(a) shows that IgA was only partially retained by the HPAC 
column. This is in agreement with other work which showed that Protein 
A binds to IgA2 but not to IgAl (8). Figure 1(b) shows that only an 
insignificant fraction of IgM was retained by the column. 
Quantitative results for immunoglobulin analysis could be 
adversely affected by the nonspecific adsorption of other serum com­
ponents if these components were co-eluted by the pH change. Since 
albumin is the only protein present in greater concentration in blood 
serum than the immunoglobulins (2), it is most likely to cause such a 
nonspecific interference. Figure 2(a) shows that no measurable amount 
of albumin was retained by the HPAC column. 
Figure 2(b) is a chromatogram of a pure IgG standard solution. 
Very little IgG eluted unretained. Since Protein A does not bind IgG3, 
the unretained peak should have been slightly larger based on the usual 
fraction of IgG3 present in IgG (6,7). Perhaps the IgG sample used 
here had a lower than normal percentage of IgG3. Figure 2(c) shows 
the analysis of a reference blood serum sample without any dilution or 
pretreatment. 
Figure 1. Analysis of 10 uL injections of 2 mg/mL human IgA (a) and 
IgM (b). Approximately 30% of the IgA was retained, while 
only a trace of IgM was retained. The nonretained 
fractions eluted at 0.7 min, while the retained protein 
was eluted at approximately 3 min by the step change in 
mobile phase pH.. Most of the baseline disturbance at 3 min 
for the IgM sample was caused by the solvent change 
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Figure 2. Analysis of 3 uL injections of 50 mg/mL human albumin (a), 
11 mg/mL human IgG (b), and an undiluted reference serum 
sample containing 8.8 mg/mL IgG (c). The nonretained peak 
from the IgG sample is about 3% of the total absorbance of 
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Electrophoresis was performed on pooled, concentrated fractions 
collected from the HPAC columns. Using the retained fraction from the 
pure IgG standards, one major electrophoretic band and several very 
faint bands were observed. The faint bands may be fragments of IgG 
(14). The major band of the nonretained fractions from the IgG 
standards migrated the same distance as-the IgG band in the retained 
fraction. This band was probably IgG3. A few faint bands were also 
observed. 
The major band from the retained blood serum fractions corre­
sponded to IgG. IgA, since it has almost the same molecular weight as 
IgG (Table I), could not be resolved from the IgG with this technique. 
A few faint bands were also observed. A band corresponding to IgM was 
not observed. 
Similarly, the eluent fractions were qualitatively profiled with 
an immunological assay. The nonretained fraction was found to have 
IgA, IgM and HSA. The retained fraction was found to contain IgGl, 
IgG2, IgA and HSA. Qualitatively, IgA and HSA were observed to be 
trace components of the retained fractions. Neither Ig63 nor IgG4 was 
found in either the retained or the nonretained fractions. These 
subclasses are minor components of total IgG and could be below the 
detection limit of the Ouchterlony technique. 
The results of these studies may be summarized to qualitatively 
describe the absorptive properties of the Protein A support. All of 
these studies indicated that IgM was not retained by the column. This 
is a surprising result since Protein A columns have been used for the 
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purification of IgM from blood serum (9). This discrepancy needs to be 
examined further. 
IgA was found in both retained and nonretained fractions. Quali­
tatively, the immunological assays indicated that the majority of the 
IgA was nonretained as was indicated by the HPAC studies. This 
distribution of IgA in both the retained and nonretained fractions was 
expected as there are two IgA subclasses, only one of which is reported 
to bind with Protein A (4,8). Similarly, IgG would be present in both 
of these fractions. This was indicated by the HPAC and electrophoretic 
studies. Both IgGl and IgG2 were retained as indicated by the immuno­
assay technique. A trace quantity of HSA was found in the retained 
fraction. This is probably due to some type of nonspecific retention 
mechanism. 
Figure 3 shows a calibration curve of peak height vs. IgG concen­
tration prepared using the pure human IgG standards. Table II compares 
the IgG concentrations for three standard reference sera analyzed by 
the manufacturer by RID with the concentrations determined by HPAC 
using the calibration curve of Figure 3. There is good agreement 
between the two sets of values. 
A common practice in clinical chemistry is to use reference sera 
as standards. The reference sera AI-AIII of Table II were used to 
prepare the calibration curve shown in Figure 4. A second set of 
reference sera, BI-BVI, was quantitated using this curve. The results 
are shown in Table III. Again, the results were in good agreement with 
the RID values, even for the two samples (BI and BII) which were not 
within the range of the calibration curve. 
Figure 3. Calibration curve prepared using human IgG as standard. 
The heights of the retained peaks are plotted 
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Table II. Comparison of reference sera analyzed by RID 
and by HPAC with IgG as standards 
[IgG] (mg/mL) 
Serum sample 
RID HPAC 
AI® 17.50 17.2 
All 8.75 8.9 
AIII 2.92 3.6 
®This sample only was diluted 1:1 with buffer. 
Figure 4. Calibration curve prepared using reference serum samples 
as standards 
44 
0*-
0 5 10 15 20 
IgG (mg/mL) 
45 
Table III. Comparison of reference sera analyzed by RID and 
by HPAC with other reference sera as standards 
[IgG] (mg/mL) 
Serum Sample 
BI 28.15 28.3 
BII 22.55 25.7 
Bill 16.90 17.0 
Biy 11.25 10.7 
BV 5.65 6.1 
BVI 1.69 1.3 
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CONCLUSIONS 
The data presented suggest that this HPAC method measures the IgG 
concentration of blood serum. The reference serum samples all 
contained nearly the same relative concentrations of the major immuno­
globulins (74% IgG, 15% IgA, 11% IgM). The agreement shown in Table 
III would be expected to be good no matter which immunoglobulins were 
retained by the column. The good agreement of sera and IgG standards 
shown in Table II could have resulted if IgG3 was not retained, but 
this difference could have been corrected by the expected partial 
retention of IgA. 
In spite of these uncertainties, it is clear that this HPAC method 
may be very useful as a rapid screening procedure for the determination 
of immunoglobulins in blood serum. Very small samples were needed— 
3 jiL or less of undiluted serum. Analysis times were on the. order of 
4 min. The columns have long lifetimes—one column which contains 1.1 
mg of Protein A has been used in our laboratory for approximately 1000 
separations over a period of two years. 
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SECTION II. 
OPTIMIZATION OF PROTEIN IMMOBILIZATION 
ON 1,1'-CARBONYLDIIMIDAZOLE-ACTIVATED 
DIOL-BONDBD SILICA SUPPORTS 
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SUMMARY 
The activation of diol-bonded silica with 1,1'-carbonyldiiraidazole 
and the coupling of protein ligands were examined as a function of 
activation conditions, coupling time, buffer, salt and pH, It was 
found that extensive sonication and vacuum-degassing during the 
activation step significantly increased the amount of ligand coupled. 
In the coupling step, it was found that a subpopulation of active 
groups was resistant to hydrolysis and resulted in increased coupling 
yields of ligand over a six day reaction time. The coupling and 
hydrolysis reactions were faster in carbonate buffer than in phosphate 
buffer, but the overall yields were similar. Coupling yields of 
several proteins were found to be relatively insensitive to pH over the 
range 4 to 8. 
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INTRODUCTION 
The reagent most often used in the preparation of an affinity 
adsorbent is cyanogen bromide. This method was developed by Axen and 
Porath (1) and is illustrated in Figure 1. The initial step is the 
formation of reactive sites on the support. The CNBr reagent forms 
imido carbonate and cyanate intermediates with vicinal diol groups of 
the support. These reactive groups are capable of reacting with a 
primary amine of the ligand, forming a covalent isourea link between 
the ligand and the support. The selection of proper pH for the ligand 
coupling step is dependent upon the pK^ of the ligand amine. Coupling 
pH should be chosen to maximize the aimount of neutral ligand amine. A 
wide variety of ligands has been attached by this method. These range 
from enzyme cofactors such as NAD to antibodies and other proteins 
(2,3). 
Though the cyanogen bromide method is the most popular, it has 
several limitations (4). The isourea coupling group has a pK^ of 10.4. 
An anionic exchange site is thus introduced at typically used pHs of 
2-8 (3). Another problem in using cyanogen bromide lies with the 
stability of the isourea group. The reactivity of the bond is enhanced 
by pHs greater than 5 and elevated temperatures (3,4). Affinity 
ligands are thus lost from the column as the unstable isourea linkage 
breaks. 
High performance affinity chromatography (HPAC) requires a high 
performance solid support. Porous silica is the most common example of 
Activation of polysaccharide chromatographic supports with 
the cyanogen bromide reagent. The exact nature of the 
reactive intermediate is uncertain 
1) pH < 10 
2) LIGANDlNMj} 
LIGAND 
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such a support (5). Silicas are limited in this use by the irrevers­
ible nonspecific surface adsorption of biopolymers. This adsorption 
phenomenon can be minimized by derivatizing the silica surface. 
Glycidoxypropyltrimethoxysilane (GOPS) is the most common such deriva-
tization reagent (6). GOPS covers the silica surface, minimizing 
nonspecific adsorption and provides epoxy groups capable of further 
reactions for ligand immobilization (5) as illustrated in Figure 2. 
Epoxy silica can either be used for the direct immobilization of 
ligands or further modified for the indirect immobilization of the 
ligand. The epoxide group is subject to nucleophilic attack. Ligands 
with amine, thiol or hydroxy groups can be easily attached by the 
direct method (5) as shown for amines in Figure 3. N®[N-(6-amino-
hexyl)carbamoylmethyl]NAD (5), 3-aminobenzeneboronic acid (7), and 
Cibacron Blue dye (8,9) are examples of ligands attached by this 
method. 
The direct method, although the simplest approach, has disadvan­
tages. The reaction is very slow, often requiring 5 days under optimum 
conditions. To speed the reaction, high concentrations of expensive 
affinity ligands are used. Also, the high pH and temperatures may have 
undesirable effects (4). Unreacted epoxy groups must be eliminated 
after ligand immobilization. The common method for this is acid 
hydrolysis (pH 2, 3 hrs, 50°C). The addition of 2-mercaptoethanol is a 
milder method for use with delicate ligands (5), though ligand activity 
may be compromised. 
Figure 2. Derivatization of the silica support with GOPS. The 
reaction is done under aqueous conditions to promote 
polymerization of GOPS and maximize the coverage of the 
silica support 
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Figure 3. The immobilization of primary amine-containing ligands 
on epoxy-silica supports 
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The indirect coupling approaches share a common first step, the 
acid hydrolysis of the epoxy group. This produces a vicinal diol group 
capable of further functionalization as illustrated in Figure 4. 
Essentially, the indirect approaches "activate" the support by 
introducing a good leaving group onto the derivatized silica. This 
active intermediate thus simplifies the actual ligand immobilization. 
The Schiff's base or aldehyde method presented in Figure 5 has 
been used to immobilize N®(6-aminohexyl)-AMP, anti-HSA (10), insulin 
(11) and Concanavalin A (12) to derivatized silica. The production of 
aldehyde silica is the first step in this synthesis. Sodium periodate 
is added to oxidize the vicinal diol to an aldehyde group. In the 
second or ligand coupling step, the ligand with a free primary amine is 
added to the suspension of aldehyde silica. This primary amine forms a 
Schiff's base with the derivatized silica, which is finally reduced to 
a secondary amine with sodium cyanoborohydride (5,12). This method is 
faster than the direct ligand coupling and much better suited for 
proteins. Any unreacted aldehyde groups may be reduced to alcohols 
with NaBH4 (5). 
Reactive sulfonyl chlorides are known to be good leaving groups 
(13). One of the indirect methods uses tresyl chloride, a sulfonyl 
chloride, as the leaving group and is illustrated in Figure 6. The 
tresyl chloride is easily reacted with the diol silica in the activa­
tion process (13,14). The degree of activation is easily controlled 
and can be determined by elemental analysis (14). The immobilization 
reaction is much faster than the direct coupling of ligand. It is also 
Figure 4. Acid hydrolysis of the epoxy group to form a diol or 
glycerol hydrophilic layer over the support 
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Figure 5. Preparation of aldehyde-silica and coupling of a primary 
amine-containing ligand to the aldehyde-silica 
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Figure 6. Activation of the diol-silica with tresyl chloride and 
coupling of a primary amine-containing ligand to the 
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more versatile than direct coupling, with a wider pH range (6-8) and 
lower coupling temperatures may be used to enhance ligand activity. 
Examples of ligands so attached are soybean trypsin inhibitor (STI) and 
N®-(6-aminohexyl)AMP (13,14). 
Another activation reagent used with HPAC applications is 1,1'-
carbonyldiimidazole (GDI). The use of GDI as an activating agent for 
affinity chromatographic matrices is illustrated in Figure 7. It was 
first demonstrated by Bethell and coworkers in a series of papers (IS­
IS) and more recently by other workers (20-25). GDI has also been used 
for the coupling of proteins to polyethylene glycol (26), and is well 
known as a synthetic reagent (27). 
The great advantage of GDI for affinity adsorbent preparation is 
that the alkyl carbamate linkage formed between a hyroxylic support and 
an amine-containing ligand is neutral (15). This is in contrast to 
other immobilization methods such as the cyanogen bromide (28,29), 
tresyl chloride (30), epoxide (30) and Schiff's base (30) methods, in 
which basic groups may be introduced when amine-containing ligands are 
coupled and which can cause nonspecific adsorption by ion exchange 
(29) . 
Bethell et al. primarily examined ligand immobilization on agarose 
matrices (15-19). They found high pH to be optimal (typically pH 8.5-
10) and that the immobilization of ligands and hydrolysis of reactive 
groups took place within approximately one day (16). Silica and glass 
matrices, such as are used in high-performance affinity chromatography 
(5,30), cannot tolerate such alkaline conditions. However, GDI-
Figure 7. Activation of diol-silica with GDI and immobilization 
of a primary amine-containing ligand to supports so 
activated 
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activated silica and glass matrices successfully coupled amine ligands 
when used at a pH of 8.5 and below (20-25), and CDI-activated glass 
matrices are commercially available from Pierce Chemical Co. (Rockford, 
IL). 
In this paper, the GDI activation reaction in an organic solvent 
of d/ol-bonded silica (prepared by the reaction of silica with GOPS 
(6)) and the coupling of an amine-containing ligand to the CDI-
activated support in aqueous solution are examined and optimized. It 
is shown that the optimum conditions for CDI-immobilization are 
significantly different when diol-bonded silica is used as the matrix 
rather than agarose. 
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EXPERIMENTAL 
Reagents 
Bovine serum albumin (BSA), soybean trypsin inhibitor (STI), 
rabbit immunoglobulin G (IgG), Protein A, eel acetylcholinesterase, 
bovine trypsin, glucosamine hydrochloride, and acetylthiocholine iodide 
were from Sigma (St. Louis, MO). Horse liver alcohol dehydrogenase 
(HLADH) and g-nicotinamide adenine dinucleotides (NAD and NADH) were 
from Boehringer Mannheim (Indianapolis, IN). The HLADH was further 
purified according to a published procedure (31). Reagents for the 
bicinchoninic acid (BCA) protein assay were from Pierce (Rockford, IL). 
LiChrospher SI500, SIIOOO and SI4000 silicas were from Rainin (Woburn, 
MA) . 
Methods 
Diol-bonded LiChrospher SI500, SIIOOO and SI4000 were prepared as 
described previously (16). The optimized CDI-activation and ligand 
coupling conditions for LiChrospher SI500 diol-bonded silica were 
scaled to a uniform set of conditions as follows: 1.0 g of diol-bonded 
silica was suspended in 1.0 mL of acetonitrile (dried over molecular 
sieves) containing a tenfold molar excess of GDI relative to the diol 
groups in the silica. The suspension was degassed by sonication under 
aspirator vacuum for 15 min and then shaken at room temperature for an 
additional 30 min. The activated silica was filtered, washed with 
acetonitrile, and sucked dry on a medium-porosity sintered-glass 
filter. The activated matrix was suspended in 10 mL of the coupling 
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buffer (0.1 M phosphate or carbonate of the desired pH) and degassed 
for 5 min. The affinity ligand was then added (10-100 mg protein), and 
the volume was adjusted to 20 mL with deionized water. The suspension 
was shaken at 4''C in a water bath for six days. The support was washed 
with buffer or water and collected by filtration or centrifugation. 
A spectrophotometric assay was used to determine the degree of GDI 
activation of the diol-bonded silica. Imidazole standards, CDI-acti-
vated silicas and diol-bonded silica blanks (1-3 mg) were suspended in 
1 mL of 3 mM phosphate buffer (pH 10), sonicated and degassed, then 
boiled for 30 min to hydrolyze the imidazoyl carbonate reactive inter­
mediate. The silica was removed by centrifugation, and the imidazole 
concentration of the supernatant was determined by absorbance at 210 nm. 
Immobilized glucosamine was determined by the alkaline ferri-
cyanide assay (32). Immobilized protein was determined by either the 
Lowry protein assay (33) or the Pierce Chemical Co. bicinchoninic acid 
protein assay. In all of these assays, blank values were determined 
using diol-bonded silica samples. The silica was removed by centrifu­
gation prior to absorbance measurement. 
The activities of immobilized HLADH (31) and acetylcholinesterase 
(34) were determined by enzyme assays. The activities of immobilized 
STI and Protein A were determined from chromatographic breakthrough 
curves (35) of trypsin and IgG, respectively. 
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RESULTS AND DISCUSSION 
Activation Step 
The CDI-activation of agarose has typically been performed for 15-
30 min in dioxane (15-19), acetone (15,19,23) or dimethylformamide 
(19,26) at room temperature. In our work, acetonitrile was used as the 
solvent, since better"coupling yields were obtained than with dioxane, 
dimethylformamide, dimethylsulfoxide and chloroform (36). In addition, 
sonication and vacuum degassing of the suspension were used to help 
remove air from the pores of the matrix. Table I indicates the effect 
of varying the activation parameters on the amount of protein coupled. 
From Experiment 1, it was apparent that increasing the duration of the 
sonication/degassing step significantly increased the amount of ligand 
coupled. Increasing the total activation time, Expt. 2, gave a smaller 
relative increase in yield. It thus appeared that the 
sonication/degassing process helped to facilitate the reaction between 
the diol-bonded phase and the GDI. 
Since the acetonitrile evaporated as the degassing time increased, 
Expt. 3 was performed to see whether the change in GDI concentration 
was important. The results indicated no effect of changing activation 
volume and GDI concentration. 
Further experiments were performed to determine whether extensive 
sonication fractured the silica. Such fracturing could lead to non­
specific adsorption of protein on the newly exposed bare silica 
surface. Treatment of several types of diol-bonded silica under 
conditions identical to the usual activation and coupling conditions. 
Table I. Activation of 0.1 g of Licrospher S1500 diol 
Expt. 
Sonication/degassing 
duration (min) 
Total activation 
time (min) 
Activation solution 
volume (mL) 
Coupling 
time (d) 
BSA coupled 
(mg/g silica) 
1 1 31 l.oa 2 2.4 
3 33 1.0% 2 2.9 
10 40 l.oa 2 3.8 
2 15 15 l.oa 6 7.1 
15 45 l.oa 6 7.0 
3 15 45 0.25-paste 6 7.0 
15 45 0.5-0.25 6 7.0 
15 45 1.0-0.75 6 7.3 
^Initial volume. 
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but without GDI, led to the immobilization of 0.15 ± 0.05 mg BSA/g 
silica. Thus, no significant damage to the silica was indicated. 
The imidazole assay was used to assess the degree of activation of 
diol-bonded silica as a function of the surface area of the support. 
Using diol-bonded silica matrices with a surface area of 6, 20 and 50 
m^/g and a diol coverage of 17, 72 and 190 umol/g, respectively, with a 
tenfold excess of GDI yielded approximately one imidazole per diol 
group (13, 72 and 156 umol imidazolyl carbonate/g silica, respectively, 
as shown in Fig. 8). In terms of surface coverage, the diol content 
averaged 3.6 umol/m^ (roughly equivalent to 1.5 monolayers (37)), while 
the imidazolyl carbonate coverage was 3.2 umol/m^. This activation 
level can be compared to 1.6 nmol/m^ obtained with diol-bonded 
controlled-pore glass (GPG) (22), 0.4 nmol/m^ with the GDI-activated 
CPG sold by Pierce, and 1.6-3.0 nmol/m^ obtained with tresyl chloride-
activated diol-bonded silica (31). 
To prevent multipoint attachment of macromolecules and a conse­
quent decrease in ligand specific activity (38), it is sometimes 
necessary to use low activation levels. Figure 9 shows that low levels 
of activation were achieved by decreasing the amount of GDI used. In 
general, the appropriate amount of GDI to use must be determined 
empirically, since the yield of the activation step was low (11%) . 
The activation levels of cellulose and agarose have also been varied; 
however, the yields were higher (35-70%) (15,16,19). 
."'.'jure 8. Variation in diol coverage (#), in; dazolyl carbonate 
content (•), and amount of BSA coupled under "high" (+) 
and "low" (X) concentration conditions as a function of 
the surface area of the support 
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Hydrolysis of Active Groups 
Bethe11 et found that the imidazolyl carbonate groups were 
lost by hydrolysis in water at room temperature during reaction times 
ranging from 1.5 h at pH 11 to 30 h at pH 5 (18). Studies of diol-
bonded silica were performed in which buffer and pH were varied and the 
imidazole assay was used to measure the loss of imidazole. The results 
were imprecise, but the general trend was that hydrolysis was very slow 
in water and phosphate buffer (6 d at pH 6 and 8) and moderately slow 
in carbonate buffer (2-4 d at pH 8). It appeared that there might be 
two subpopulations of active groups present, one of which was 
hydrolyzed immediately upon contact with water and one which was more 
stable, and the rate of hydrolysis depended on the buffer salt and the 
pH. 
Coupling of Glucosamine 
The monovalent ligand glucosamine was used to determine which 
subpopulation of active groups was primarily responsible for coupling 
ligands. As shown in Table II, the immobilization rates paralleled the 
loss of the more stable sites. At pH 8 in carbonate buffer, coupling 
was complete after 2 days. In phosphate buffer the reaction was 
complete after approximately 4 days. It is interesting that the same 
amount of glucosamine was immobilized in both carbonate and phosphate 
buffers. Apparently, both immobilization and hydrolysis reactions were 
faster in carbonate buffers. 
The yield of the coupling reaction was only about 11% relative to 
the initial number of active sites. The most ligand attached in this 
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Table II. Immobilization of Glucosamine 
Glucosamine coupled (umol/g) 
Buffer pH 0.5 d Id 2d 4d 6d 
phosphate 6 7 10 17 19 17 
phosphate 8 3 16 12 18 15 
carbonate 8 5 16 18 20 18 
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laboratory by the GDI method was 1.0 umol/m^, or ca. 30% relative to 
the number of diol groups. It thus appears that rapid hydrolysis of 
many of the active groups ultimately limits the maximum density of 
immobilized ligands. Using GDI-activated agarose, Hearn et al. coupled 
several monovalent ligands at pH 9-11 with yields of 20-70% relative to 
. the initial number of active groups (16). 
Goupling of Albumin and Immunoglobulin G 
BSA and IgG were chosen to study the immobilization of proteins. 
Replicate immobilization of BSA yielded a relative standard deviation 
of 13%. This figure is probably representative of the precision of the 
immobilized protein data presented below. 
The effects of several buffer salts on the immobilization of BSA 
were examined at pH 8.0 in 0.05 M buffers. The concentrations of BSA 
attached were: phosphate buffer, 31 mg/g; carbonate, 34 mg/g; borate, 
31 mg/g; acetate, 28 mg/g; and trishydroxymethylaminomethane (TRIS), 
22 mg/g. Thus, all of the buffers, except TRIS, yielded similar 
results. TRIS and other amine-containing buffers should not be used 
for coupling. 
Ionic strength effects were briefly examined. When 0.005 M phos­
phate (pH 8) was used, one-half as much BSA was immobilized as when the 
buffer concentration was 0.05 M. Increasing the ionic strength with 
NaCl slightly increased coupling. Similar effects have been observed 
with other activating agents (39). However, increasing the ionic 
strength with phosphate sometimes led to decreased coupling yields. 
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Carbonate and phosphate buffers were selected for further study. 
Two concentrations of IgG and BSA were used in these studies. "High" 
concentration will refer to the use of 5 mg/mL protein concentrations 
with a maximum immobilization level of 100 mg/g. "Low" will refer to 
one-tenth of these concentrations. 
Figure 10 shows the immobilization of BSA over a pH range of 3 to 
9. There was a broad maximum centered at pH 4-5. Previous workers 
utilized high pH for coupling to agarose because monovalent ligands 
coupled best near the pKg of the amine group (16,24). It was thus 
somewhat surprising to find such a low optimum pH for the BSA. This is 
very advantageous, since silica matrices are not stable above pH 8. 
The time-dependence of immobilization was further examined at pH 
6 and 8 (Table III). The data exhibited the same trends as the 
glucosamine data in Table II. Reaction was more rapid in carbonate 
than phosphate buffer, but the total amount of protein coupled was 
similar for both buffers. For BSA, yields were higher at pH 6 than at 
pH 8, in agreement with Figure 10. The yields reached about 90% under 
"low" conditions and 50% under "high" conditions. IgG appeared to be 
significantly more reactive than BSA; 100% immobiliztion was observed 
under most conditions. It should be noted that 100 mg IgG/g 
LiChrospher SI500 was close to monolayer coverage. Similar coverages 
have been obtained for tresyl chloride-activated diol-bonded silica 
(31) . 
Immobilization experiments were performed on matrices of variable 
surface area. Just as in the activation step, the amount of protein 
Figure 10. The pH dependence of BSA cou£)ling using phosphate buffer 
BSA coupled (mg/g silica) 
a> 
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Table III. Immobilization of BSA and IgG 
Protein coupled (mg/g) 
Protein Concentration Buffer pH Id 2d 4d 6d 
low phosphate 6 8 8 8 8 
high phosphate 6 31 45 48 57 
low phosphate 8 6 6 6 6 
high phosphate 8 28 29 37 42 
low carbônate 6 11 12 12 13 
high carbonate 6 43 47 47 52 
low carbonate a 8 7 7 9 
high carbonate 8 26 30 34 34 
high phosphate 6 97 100 101 108 
high phosphate 8 82 100 103 118 
low carbonate 6 10 10 11 12 
high carbonate 6 118 109 111 111 
high carbonate 8 61 63 63 63 
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Table IV. Effect of the amount of GDI on protein coupling 
Protein coupled (mg/g) 
mol CDl/mol diol BSA-low BSA-high IgG-low 
10. 5.3 19.6 7.1 
1. 1.0 1.1 • 3.1 
0.1 0.4 0.7 2.1 
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attached increased linearly with the surface area of the matrix. Using 
the same matrices described earlier, "low" and "high" BSA concentra­
tions yielded surface coverages of 0.2 and 0.6 mg BSA/m^, respectively. 
BSA was immobilized with decreased amounts of GDI (Table IV). As 
expected from the activation study (Pig. 9), the coupling yields 
dropped rapidly as the amount of GDI decreased. Immobilized IgG yields 
were less affected than BSA yields. In general, the high sensitivity 
of the yield to the amount of GDI made it difficult to control coverage 
by this means. 
Deactivation of Excess Reactive Groups 
Active groups remaining after ligand immobilization are frequently 
removed by reaction with ethanolamine. To test the effectiveness of 
ethanolamine in removing imidazolyl carbonate active groups, a solution 
of 0.08 M ethanolamine in 0.05 M phosphate buffer (pH 8) was allowed to 
react with GDI-activated diol-bonded silica for various lengths of 
time. The ethanolamine solution was then removed by filtration, 
replaced with a glucosamine solution, and allowed to react with any 
remaining active sites for an additional 6 days. The amount of glucos­
amine coupled is listed in Table V. It is apparent that ethanolamine 
was not much more effective at removing active groups than simple 
hydrolysis in buffer. This may be due to the high pK^ of ethanolamine 
(9.5, vs. 7.7 for glucosamine and the near neutral buffer pH values 
used). A better alternative for ensuring removal of active groups 
would be to perform the coupling in carbonate buffer or to treat the 
matrix with carbonate after coupling of ligand is complete. 
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Table V. Removal of active groups with ethanolamine 
Duration of reaction Glucosamine 
in ethanolamine (d) coupled (pmol/g) 
0 18 
1 7 
2 a 
4 2 
6 2 
control^ 5 
d hydrolysis in buffer. 
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Immobilization of Various Proteins 
STI, Protein A, acetylcholinesterase and HLADH were immobilized at 
several pH values in phosphate buffer. The matrices were then assayed 
for protein content and biospecific activity. It should be noted in 
these experiments that the amount of protein attached could be 
increased by increasing the concentration and amount of protein used in 
the coupling step. However, the percentage yields declined. This same 
trend can be seen in Table III for the BSA data and has been observed 
for CDI-activated cellulose (23). 
Both the yield and activity of immobilized STI (Table VI) were 
moderately insensitive to pH in the range of 5-8. The yield was 
highest at pH 5 and the specific activity, based on the binding of 
trypsin, was almost constant over the pH range 5-7. The manufacturer 
indicated a specific activity of 1-3 mg trypsin/mg STI for the STI; 
thus, almost all of the activity was preserved during immobilization. 
Protein A from Staphylococcus aureus, which binds to the region 
of several classes of immunoglobulins, was immobilized at pH 4-8 (Table 
VI). Both the yield and specific activity for binding IgG increased 
slightly as the pH decreased from 8 to 4. However, the specific 
activity was much lower than the manufacturer's value of 13 mg IgG/mg 
Protein A. A comparative study of three coupling methods has shown 
that GDI is a poor reagent for the immobilization of Protein A (25). 
Acetylcholinesterase appeared to be immobilized in highest yield 
at pH 4 (Table VII). However, in a second experiment, the highest 
yield was at pH 8. In either case, pH 4 proved unsuitable because the 
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Table VI. Immobilization of STI and Protein A 
Ligand pH 
Protein 
coupled (mg/g) 
Test 
solute 
Specific activity 
(mg test solute/mg ligand) 
STia 5 19.9 trypsin 2.7 
6 18.5 2.6 
7 17.3 2.8 
8 17.6 2.1 
Protein^ 4 10.2 IgG 0.7 
6 8.6 0.6 
8 9.0 0.5 
&STI applied; 200 mg/g silica. 
^Protein A applied; 10 mg/g silica. 
ê 
91 
Table VII. Immobiliztion of acetylcholinesterase and HLADH 
Ligand PH 
Protein 
coupled (mg/g) 
Specific activity 
(immobilized/native) 
Acetylcholinesterase^ 4 3.8 0.4 
6 2.7 1.1 
8 2.6 1.0 
HLADH^» 5.1 15.5 0. 
6.5 11.7 1.0 
8.0 10.7 1.0 
^Acetylcholinesterase applied; 11 mg/g silica. 
^HLADH applied: 19.4 mg/g silica. 
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specific activity was significantly less than at pH 6 and 8, where 100% 
of the initial activity was retained during immobilization. 
HLADH, immobilized in the presence of NADH, ZnSO^ and isobutyr-
amide (31), was coupled in highest yield at pH 5.1, but was found to be 
totally inactive (Table VII). HLADH is known to be denatured in 
buffers of pH <5 (40), and this situation occurred briefly during pH 
adjustment of the protein solution. However, at pH 6.5 and 8.0, the 
HLADH was immobilized with 100% retention of activity. Both the yields 
and activities were comparable to those obtained with tresyl chloride 
(31). 
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SECTION III. 
STUDIES ON THE DESORPTION OF IgG FROM IMMOBILIZED 
PROTEIN A USING THE PEAK DECAY MODEL: 
A GENERAL METHOD FOR QUANTITATIVELY DESCRIBING 
THE ELUTION OF ANALYTE FROM AN AFFINITY SUPPORT 
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SUMMARY 
The dissociation of IgG from immobilized Protein A was studied. 
For this work the Peak Decay (PD) kinetic model was used. The 
derivation of this model as well as a computer simulation of this model 
are reviewed. The application of the computer simulation for the 
estimation of the chromatographic parameters required to produce the PD 
effect is demonstrated. Using the PD model, the dissociation kinetic 
rate at 25°C was found to be 0.008 sec"^. This value is in reasonable 
agreement with literature values for the native dissociation of the 
Protein A-IgG complex. Additionally, the kinetics of low pH denaturing 
elution were studied with the PD model. An IgG dissociation rate of 
1.2 sec"l was observed with this type of elution. The activation 
parameters of both the naturlng and denaturing dissociation processes 
were determined and found to be in reasonable agreement with literature 
values. The suitability of the PD model for the study of protein-
protein interactions as well as high affinity biocomplexes (Kgq» 10®) 
is demonstrated. 
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INTRODUCTION 
Solid phase techniques have become popular alternatives for 
biochemical analysis because of the stability and reusability they 
impart to the immobilized biochemical reagent or ligand. Enzyme 
electrodes (1), Enzyme linked Immunosorbent assay (ELISA) assays (2) 
and affinity chromatography (3) are examples of techniques using 
immobilized biochemicals. Since these applications are often operated 
in the nonequilibrium mode, the biocomplex association and dissociation 
kinetic rates as well as the affinity or equilibrium constants are 
important considerations in experimental design (4,5,6). Unfortun­
ately, the extrapolation of these parameters as determined in free 
solution to the solid phase is often not valid. The presence of the 
solid support and the immobilization chemistry used can alter the 
microenvironment of the bioligand (1). Additionally, the immobiliza­
tion of the ligand and the presence of the solid support impede the 
free diffusion of the analyte and eliminate diffusion of the ligand. 
This is significant since free diffusion has often been observed to be 
the rate-limiting step for free solution reactions (1). 
The determination of biocomplex dissociation kinetics with 
affinity chromatographic techniques has been previously described 
(4,7). These approaches have typically used a general model for 
affinity chromatography with biospecific elution. This model is 
presented in Figure lA and is descriptive of "reversed-role" affinity 
chromatography where both the analyte (A) and the inhibitor (I) bind 
Figure 1. Models used to describe the affinity chromatographic process 
A) The general model for retention of analyte (A) on an 
affinity ligand (L) with biospecific elution using 
inhibitor (I). Both I and A bind with the same site on 
the ligand with this binding competition for ligand 
represented as (X). Subscripts m and p represent the 
moving and stagnant mobile phase, respectively 
B) The Peak Decay model. This model is a special case 
of the general model (see Fig. lA) where all adsorptive 
processes have been eliminated during desorption 
through the use of large [I] and rapid flow rates 
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with the same site on the affinity ligand (L) (8). Thus, both the 
inhibitor and the analyte compete for available ligand sites. In this 
work all inhibitors will be assumed to be of the competitive type. 
The inclusion of the diffusion-controlled mass transfer processes 
between the intra-pore stagnant mobile phase and the inter-pore moving 
mobile phase is more descriptive of a macromolecular chromatographic 
behavior (9). Additional parameters of this model are: 
K3 - equilibrium constant for formation of the analyte affinity 
ligand complex 
k] - association rate constant for the analyte and affinity 
ligand complex 
k_3 - dissociation rate constant describing dissociation of the 
analyte-affinity ligand complex 
K2 - equilibrium constant for affinity ligand-inhibitor complex 
k2 - rate constant for the formation of the affinity ligand-
inhibitor complex 
k_2 - rate constant for the dissociation of the affinity ligand-
inhibitor complex 
ki - rate of diffusion-controlled mass transfer of analyte and 
inhibitor from the moving mobile phase to the stagnant 
mobile phase 
k_i - rate of diffusion-controlled mass transfer of analyte and 
inhibitor from the stagnant mobile phase to the moving 
mobile phase 
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Each of these kinetic processes and the chromatographic system 
contribute to the broadening of the analyte band. This broadening is 
quantitatively described by the Height Equivalent of a Theoretical 
Plate (HETP) for the analyte band. The contributions of each of these 
broadening processes are summed in the HETP term. It is possible to 
independently estimate the contribution to broadening from each of 
these nonabsorptive processes and obtain the biocomplex kinetic 
broadening (absorptive processes) contribution by difference. 
Equations have been derived relating the HETP contribution to the 
actual kinetic rates of analyte-ligand complexation. These procedures 
are, however, quite complex and significant errors may be introduced 
(10). 
The biocomplex dissociation rate may be easily determined by 
modifying the design of the affinity chromatographic experiment. The 
Peak Decay (PD) model is one special case of the general model designed 
specifically for the estimation of biocomplex dissociation kinetics. 
It is presented in Figure IB (8). The PD model is a consecutive 
reaction sequence or a biphasic process (11). The actual dissociation 
is followed by the diffusion of the analyte from the pore and into the 
moving mobile phase followed by the elution of analyte from the column. 
The adsorptive processes are negated experimentally with high inhibitor 
concentrations to favor formation of the inhlbitor-ligand biocomplex 
(once a ligand site has become available) and rapid eluent flow rates 
to elute the dissociated A from the column before it can diffuse back 
into the pores of the support. 
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As this system is designed to operate in a nonequilibrium manner, 
very poor band shapes are produced. The initial response is a rapid 
rise with a tail slowly decaying to baseline. An example of such a 
peak is presented in Figure 2 and illustrates the origin of the peak 
decay nomenclature. Ideally, the rate of decay is indicative of the 
dissociation of analyte from the ligand. 
Unique to the design of the PD model is the ability to apply the 
model for the estimation of the dissociation kinetics of nonspecific 
elution methods (8). These nonspecific elution techniques, such as 
change of eluent pH or the addition of organic solvent or chaotropic 
ion to the eluent, involve some type of biocomplex denaturation leading 
to the dissociation of the biocomplex and elution of the analyte. This 
situation is analogous to the use of inhibitor with biospecific elution 
technique. Used in this manner the PD method could measure the rate of 
denaturation of the biomolecules. The various nonspecific elution 
techniques have been shown to dissociate and denature the affinity 
complexes in specific mechanisms (12). The PD method should be suit­
able for the study of these various nonspecific elution techniques (8). 
This model has been successfully applied to the study of 
Concanavalin A sugar biocomplexes (Kgg = 10^) (13). The PD model 
should also be useful for the study of higher affinity systems which 
have proven difficult for the classical chromatographic kinetic 
techniques. The Protein A IgG affinity complex should be useful as a 
Figure 2. Peak decay profile^ calculated from Equation la for 
the conditions k_2/k_3 = 10. Taken from Ref. 8 
Concentration 
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model for higher affinity (Kgq > 10®) protein complexes (9). 
Protein A is a cell wall protein isolated from the Staphylococcus 
aureus bacteria. Structurally, protein A is composed of five subunits 
arranged in a linear form with a molecular weight of 42 kD. Four of 
these subunits are homologous and capable of binding with the Fc region 
of many mammalian immunoglobulin proteins (14) while the fifth is 
located at the C-terminal and anchors the native protein to the 
bacteria cell wall (15). 
In these studies, Protein A was immobilized and used as the 
affinity ligand. Rabbit IgG was used as the analyte. Rabbit IgG 
protein has been reported to be homogeneous with respect to Protein A 
or not to exhibit subclasses which could have varying kinetic 
properties (9,16), and is readily available. The Protein A IgG complex 
forms readily at neutral pH values and rapidly dissociates at acidic pH 
values (17). 
Protein A is bivalent with respect to the binding of IgG (18). 
This is less than the optimal tetravalency and has been explained by 
steric hindrance (19). Lindmark has studied the adsorption of IgG to 
Protein A and demonstrated cooperativity between the primary and 
secondary adsorptions of IgG, with the affinity constants presented in 
Table I (20). This cooperativity results in a 40-fold decrease in the 
affinity constant of the secondary adsorption with respect to the 
primary adsorption. Sufficient IgG must be available to saturate the 
primary adsorption site before the second site fills. Secondary 
adsorption of IgG is a real complication in present experiments, since 
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Table I. Estimation of the chromatographic parameters required to 
produce the peak decay effect with various combinations of 
thermodynamic and kinetic data 
mole IgG 
primary adsorption secondary adsorption 
mole Protein A 1 1 
(M-1) 4.1 E 08 6.4 E 06 
calculated experimental 
k_3^ k_3G 
calculated 
k_3b 
experimental 
k-3'^ 
^-3 . 
(sec "1) 6.1 E -04 2.3 E -05 3.75 E -02 5.5 E -04 
rate ratio 
k-l®/k.3 3.9 E 03 10.4 E 04 64 4.4 E 03 
estimated k' 10 10 
peak decay 
parameters tm (sec) 4.9 E 02 1.3 E 04 
1 
8.0  
10 
5.5 E 02 
&k_3 calculated using K3 and k^. A kg value of 2.5 x 10^ sec"^ 
as determined by split peak kinetics (9). 
bk_i calculated as 2.4 sec"^ for the diffusion-limited case (8,9). 
°k_3 experimentally determined using heat killed Staph A with 
limiting IgG by Mayhre and Kronvall (6). 
dk_3 experimentally determined using heat killed Staph A with 
excess IgG by O'Keefe and Bennett (5). 
®Ref. 20. 
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high IgG inhibitor concentrations are required. This could introduce 
heterogeneities into the PD dissociation, as some might have a mix of 
1° and 2° desorption events. 
The study of the Protein A IgG interaction is complicated by the 
lack of a suitable competitive inhibitor (8,17,21). IgG must be used 
as both the analyte and inhibitor. A fluorescent label covalently 
attached to the analyte IgG has been proposed to distinguish between 
the analyte IgG and the inhibitor IgG (8). Dandliker and Levison have 
used a fluorescein label attached to IgG antibody for the study of 
antibody antigen kinetics (22-24). These reports and work by Coding 
indicate a minimal effect on the macromolecular interaction with the 
presence of the fluorescent label. 
In the theory section a brief description of the Peak Decay 
kinetic model and the derivation of the defining equations are 
presented. Additionally, a computer simulation of the PD model is 
described to allow for estimation of the suitability of the PD model to 
a particular affinity system and to estimate the experimental 
parameters required to produce the PD effect. Fundamental elution 
studies were undertaken to compare the dissociation rates under both 
naturing and denaturing conditions. Additionally, the activation 
parameters of the various elution schemes were studied for comparison 
of the elution methodology. The energetics of the PD desorption were 
studied by determining the effect of temperature on the measured PD 
rate. 
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THEORY 
Derivation of Defining Equations 
An equation describing the PD model can be derived and is 
presented as Equation la where mCAg) and m(Af.} are the total moles of 
analyte retained at t = 0 and at time t, respectively. The diffusive 
and dissociation rates are and k_3, respectively. This equation 
can be simplified with the assumption that k_3 « k_2 and by making a 
logarithmic transformation, leading to Equation lb. A theoretical 
elution profile is presented in Figure 2 (8). 
d m(At) k_ik_3m(Ao) ^^-(k_3t) _ ^-(k_it)j 
dt k_2 - k_3 
d m(A|.) 
In ( ) = In (m(Ao) k_3) - k_3 t 
dt 
As with any biphasic process, the estimation of a kinetic rate 
constant for either step of the process is most easily made if it is 
significantly smaller than the rate constant of the other step (8,11). 
If the rates are similar, the PD treatment, as based on Eq. lb, would 
fail to properly describe the system. Hence, the fundamental limita­
tion in applying the PD model is the k_i/k_3 rate ratio of a given 
biocomplex. 
Estimation of the k_]_/k_3 ratio of the experimental affinity 
system is the initial step in the application of the PD model. As 
described above, k_i is the rate of mass transport from the stagnant 
(la) 
(lb) 
Ill 
mobile phase to the moving mobile phase. This is a diffusion-
controlled process and is affected by interactions between the support 
and the analyte. This diffusion of the analyte is restricted by the 
geometry of the pore and support. This is expressed in Eg. 2 (25), 
where D, dp and (Y) are the analyte diffusion coefficient, particle 
diameter and tortuosity of the support, respectively. Tortuosity 
quantifies the degree of restriction of free diffusion by analyte as 
defined by Giddings and can be assumed to be 0.1 for large proteins and 
high performance silica supports. 
The k_i and rates are not equivalent as described by Eq. 2 
where Vp and Vg are the column pore volume and the column excluded 
volume, respectively. 
(Ve/Vp)ki = k_i = (2) 
dp2 
If available, the best estimate of k_3 is one obtained from free 
solution experiments. Typically, k_3 must be inferred from the free 
solution affinity or equilibrium constant (Kgq) and association rate 
(kg) data. Finally, data from similar affinity systems may also be 
used as an approximation. 
The experimental parameters affecting the generation of a PD 
profile are ligand density (moles ligand (m^)/column void volume (V^)), 
inhibitor concentration, and eluent flow rate. Unlike the fundamental 
rate ratio limitations, these parameters can be controlled to produce 
the PD effect. The relationship between the flow rate and inhibitor 
concentrations and the resulting experimental PD rate can be quite 
112 
complex. When the assumptions used to define the PD model are met, the 
measured PD rate is independent of these experimental parameters, as 
predicted by Equations la and lb. Rather than attempt a rigorous 
derivation of the effect of these experimental parameters upon the 
resulting PD rate, a more satisfactory approach is a computer simula­
tion of the experiment. This simulation may also be used to estimate 
the chromatographic parameters required to produce the PD effect (8). 
Computer Simulation of the Peak Decay Effect 
The computer simulation divides the column lengthwise into a 
series of segments. These segments are further divided into three sub-
segments representing the moving mobile phase, the stagnant mobile 
phase and the affinity ligand. The chromatographic process is approxi­
mated by introducing the analyte into the initial segment and distrib­
uting the analyte between the phases.' Elution is approximated by 
transferring the moving mobile phase to the next segment and re-
equilibrating the analyte in each segment. This is diagrammed in 
Figure 3 where the equilibration and transfer steps are demonstrated. 
This type of approach is analogous to the plate theory of chromatog­
raphy (8,9). 
As with the design of the actual experiment, it is possible to 
configure the simulation to describe the Peak Decay Model (8,13). 
Rather than eliminating the kg and k^ steps as in the derivation of the 
PD model, these adsorptive kinetic processes are included in the 
simulation. The simulation assumes that initially all of the ligand 
Figure 3. Illustration of the model used for computer simulations. 
From top to bottom, the rows represent the moving phase, 
stagnant mobile phase, and stationary phase. The flow 
is from left to right, along the length of the column. 
Taken from Ref. 8 
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sites are saturated with analyte and competitive inhibitor is contin­
uously applied to the column with the moving mobile phase. The 
inhibitor is equilibrated in the initial segment with dissociated A. 
Both I and A in the moving mobile phase are then transferred to the 
next segment. Eventually, the analyte exits the column, describing the 
simulated elution profile. From this simulated profile the overall 
desorption rate may be calculated. This simulated rate will be 
referred to as the "apparent" Peak Decay rate. Similarly, the k_3 rate 
used with the simulation is defined as the "true" Peak Decay rate. If 
the assumptions of the PD model have been met and the adsorptive 
processes minimized, the "apparent" PD rate should equal the "true" PD 
rate. Using this simulation, various flow rates and inhibitor concen­
trations have been studied, and their effect on the "apparent" PD rate 
described. 
The computer simulation is designed to use reduced parameters of 
capacity factor (k') and column residence time (t^) to represent the 
inhibitor concentration and the flow rate, respectively. The relation­
ship between inhibitor concentration and k' is presented in Eq. 3, 
niL K3 
k' = — ( ) (3) 
Vm 1 + K2 [I] 
where m%, and represent the total number of ligand sites and the 
column void volume. The residence time may be calculated from the 
column volume, the volumetric flow rate and the porosity of the 
support. For high performance supports a porosity of 0.8 is typical 
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(9). Similarly, the "apparent" PD rate is normalized by division by 
the "true" PD rate. This value is referred to as the "normalized 
slope" and is unity when the "apparent" PD rate and the "true" PD rate 
are equal. Using these techniques, the effect of various inhibitor 
concentrations and flow rates on the simulated "apparent" PD rate have 
been studied. 
The k_i/k_3 rate ratio can affect the accuracy of the "apparent" 
PD rate. The relationship of normalized PD rate with the rate ratio at 
different inhibitor concentrations is depicted in Figure 4 (8). Some 
important considerations for the application of the PD model are 
illustrated by Figure 4. The most obvious characteristic is the 
failure of the PD model to accurately estimate the PD rate at rate 
ratios between 0.1 and 10. This is a fundamental limitation of the 
biphasic process. For a given affinity system and, hence, rate ratio, 
the use of lower ,k' (higher concentration of I) results in a better 
approximation of the "true" PD kinetic rate. Similarly, more accurate 
apparent PD kinetic rates at a given k' strength are obtained with 
higher rate ratios. This is because at high rate ratios there is 
faster diffusion of the free A from the pore relative to the 
dissociation of analyte from the ligand, thus allowing for accurate 
determination of kinetic rates by Equation lb. 
In contrast to the above cases, the "apparent" PD rate is not 
accurate at rate ratios less than one. This, too, is a fundamental 
limitation of the PD model. When the rate ratio is less than one, the 
diffusion step is slower than the dissociation step and free A 
Figure 4. Plot of the normalized slope from computer simulations 
of peak decay profiles as a function of k_i/k_3 and k' 
for the conditions Vp = Vg and Lj,oi = 0. Taken from 
Ref. 8 
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accumulates in the pore. Unfortunately, at low inhibitor concentration 
(high k') free A may readsorb onto available ligand sites requiring 
strong inhibitors to sufficiently reduct k'. 
As with the inhibitor concentation study, the effect of flow rate 
on the "apparent" PD kinetic rate may be studied with the simulation. 
If too slow a flow rate is used, analyte diffusing from the pore 
accumulates in the moving mobile phase and elute as a band rather than 
being swept from the column immediately after exiting from the pore. 
Thus, the possibility of reentry of desorbed A into a second pore is 
introduced. A graphical representation of the effect of flow rate on 
the "apparent" PD rate is presented in Figure 5. The unitless value(s) 
of (tm X k) is the independent variable and the normalized slope is the 
dependent variable. The relationships of these parameters at k' values 
equal to 0.01, 0.1, 1.0 and 10 are presented. These various inhibitor 
concentrations are included so that the eluent strength selected 
previously from Figure 4 may be included in the estimation of residence 
time. Figure 5 is a grouping of several of these types of plots. The 
columns represent kinetic rate ratios of 0.1, 1 and 10. The rows 
represent Vp/Vg ratios of 1.0 and 0.1, descriptive of totally porous 
silica and nonporous chromatographic supports, respectively. These 
combinations of support and affinity systems were chosen to represent a 
wide range of possibilities for the design of the experiment (8). 
The inclusion of the eluent strength lines restates many of the 
conclusions from Figure 4. When k_2 = k_3, the model will fail to 
Figure 5. Plots of normalized slope from computer simulations 
of peak decay profiles as a function of void time 
multiplied by the smaller of k_j^ or k_3. Vp/Vg = 1 
in (a-c), Vp/Vg = 0.1 in (d-f). In (a) and (d), 
k_i/k_3 = 0.1. In (b) and (e), k_]^ = k_3. In (c) 
and (f), k_i/k_3 = 10. k' = 0.001 (O), 0.01 (#), 
0.1 (•), 1.0 (•), and 10.0 (O). Taken from Ref. 8 
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accurately describe the "true" PD rate no matter how high the inhibitor 
concentration. As in Figure 4, inhibitor concentration has a dramatic 
effect on the "apparent" PD rate at a rate ratio of 10. If higher rate 
ratio plots were available, the k' lines would begin to converge at a 
normalized slope close to unity as was seen in Figure 4. The shape of 
the eluent strength curve is also important. For each of the plots at 
low values of (tj, x k_3), the "apparent" rate is independent of resi­
dence time. As t^ is increased, this independence is lost as the plot 
"breaks" to lower values of normalized slope. The tm corresponding to 
this break increases with increasing inhibitor concentration, indicat­
ing that some readsorption is occurring at low inhibitor concentra­
tions. The results of Figure 4 indicate that this should be less 
significant at higher values of the rate ratio. Generally, the 
"apparent" PD rate is independent of t^ or flow rate at (t^ x k) values 
smaller than 0.3. From these simulations, then, the inhibitor concen­
tration and flow rate necessary to produce the PD effect for a given 
support may be estimated. 
In summary, not all affinity systems will be amenable to the PD 
model. The fundamental limitation is the rate ratio, which must be 
greater than 10. Additionally, the analyte-saturated ligand site must 
be sufficiently stable to allow washing of nonsorbed analyte from the 
column without elution of the sorbed analyte. This restriction would 
eliminate many low affinity (Kgq < 10^) systems. The lack of a suit­
able competitive inhibitor would seem to be such a fundamental limita­
tion. For such systems the use of a "tagged" analyte to saturate the 
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system and untagged analyte as competitive inhibitor has been proposed 
(8). In addition to these fundamental limitations, more practical 
problems may arise. For the particular affinity support and column 
dimensions the required inhibitor concentration and flow rate may be 
impractical. This can be addressed by using a support of appropriate 
ligand density, as calculated from Eg. 3 and Figure 4, in a column of 
proper size for the practical flow rates, as estimated from Figure 5. 
This process could result in low ligand loadings and small column 
dimensions. Under these conditions, only a very small amount of 
analyte would be retained and detection could become a problem. This 
illustrates the careful balance of these parameters that must be struck 
to produce an accurate estimate of the PD rate. 
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MATERIALS AND METHODS 
Reagents 
Fluorescein isothiocyanate (PITC), adsorbed on celite, immuno­
globulin G (rabbit), Protein A, DEAE cellulose, and Sephadex G-20 were 
obtained from Sigma (St. Louis, MO). LiChrospher SI4000 was from Merck 
(Rahway, NJ). All other chemicals were of reagent grade and were 
obtained from Fisher Scientific (Pittsburgh, PA). 
Instrumental 
The chromatographic system was a quaternary system and is 
illustrated schematically in Figure 6. The solvent delivery system was 
a Beckman (Berkeley, CA) 334 ternary system with the injection valve 
modified to act as a switching valve between the ternary system and a 
Rainin (Woburn, MA) Rabbit pump equipped with a 5 mL/min pump head. 
This switching valve configuration minimized the precolumn system 
volume so that changes in the eluent strength applied to the column 
were very sharp. This produced an essentially plug flow profile of 
eluent strength as the column was eluted. Additionally, this allowed 
for rapid changes in eluent strength and minimal pressure pulsation 
upon switching of the valve. 
The columns used for this work were of a type described previously 
and prepared from 4.6 mm ID stainless steel tubing blanks (13,26). For 
biospecific elution and pH elution, 25 mm and 6.4 mm length columns 
were used. For this work the eluent reservoirs as well as the columns 
Figure 6. Illustration of the quaternary HPLC system used in the 
peak decay studies. The injection valve has been 
modified to act as a switching valve to select from 
either the Rainin pump or the Beckman system. Strong 
eluent was delivered by the Rainin pump. The syringe 
eluent reservoirs allowed the use of small volumes of 
the IgG eluent in a convenient manner. When saturating 
the column with FITC-IgG, the waste was recycled 
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were thermostatted at 2 5 ° C ,  except during the temperature studies where 
the appropriate temperatures were used. To preserve bioactivity the 
columns were stored at 4°C while not in use. 
To monitor column effluent, a two detector system was used. The 
initial detector was a fluorometer optimized for detection of the 
fluorescein label and used to obtain the PD profile as the FTIC labeled 
analyte IgG eluted from the column. To monitor total IgG (both the 
analyte and inhibitor IgG), an Altex model 153 absorbance detector with 
a biochemical flow cell and 280 nm filter was used. This detector was 
connected in series after the fluorometer and was used to monitor the 
completion of the various saturation and washing procedures. Outputs 
from both the fluorescence and absorbance detectors were recorded 
simultaneously. The fluorescence signal was also monitored with a 
computer data acquisition system (9,13) and stored on disc for later 
analysis of the PD elution profile. 
The fluorometer detector was an extensively modified SPEX 1670 
minimate double monochromator fluorometer equipped with a DPC-2 photon 
counting device (SPEX, Metuchen, NJ). The final configuration of this 
instrument is presented in Figure 7. The fluorescence flow cell used 
with this instrument was adapted from a Kratos (Ramsey, NJ) model PS 
980 filter fluorometer and mounted into the SPEX sample compartment. 
The final focusing lens served to focus the excitation beam into the 
flow cell for maximal intensity and minimal, illuminated volume. 
Although the cell had a total volume of 35wL, only the initial seven 
liL of this volume were illuminated, minimizing the contribution of the 
Figure 7. Illustration of the fluorometric detector modified in 
our lab and used in obtaining the PD profiles 
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large cell volume to the broadening of the detected band. 
Several modifications were made to maximize the throughput of both 
the exciting and emitted radiation. On the excitation side, the slits 
were removed from the monochromator. This component thus served only 
to predisperse the radiation prior to the final excitation wavelength 
selection by an interference filter. The emission monochromator was 
removed and the PMT housing was directly attached to the sample 
compartment. A second interference filter was used to discriminate the 
fluorescent radiation from the background. Both of these interference 
filters were from Melles Griot (Rochester, NY) and were bandpass 
filters with a 10 nm PWHM. These filters were angle tunable over a 50 
nm range about the central wavelength of 500 nm and 550 nm for the 
excitation and emission filters, respectively. Prior to the final 
mounting these filters were tuned by maximizing the detector response 
to a solution of fluorescein in the flow cell. The voltage of the PMT 
was adjusted to 650 V for the optimal S/N ratio using this instrument 
configuration. A tungsten halogen lamp model 7001 from General 
Electric (Albany, NY) was operated with a Hewlett Packard power supply 
at 15 V with 63 watts DC drawn by the lamp. This was found to be 
sufficiently intense and stable. 
The analytical capability of this instrument was determined with 
fluorescein dye solutions. The column was removed and the dye sample 
was applied to the system as a flow injection bolus. Alternatively, 
the dye solution was continuously applied to the detector in a static 
technique. The limit of detection at a signal-to-noise ratio of three 
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was found to be 2 x 10~^2 moles injected and 1 x 10~® M for the flow 
injection and static techniques, respectively. Using the static 
technique with the seven uL cell, an absolute detection limit of 7 x 
10rl4 moles of dye was indicated. This compares favorably with the 
determination of fluorescein by laser fluorescence methods (27). 
Procedures 
Preparation of Material 
Dipl-bonded LiChrospher SI4000 was prepared and Protein A was 
immobilized by the Schiff's base method as previously described (9). 
The yield of total immobilized Protein A was determined with the BCA 
protein assay from Pierce (Rockford, IL) (28). The yield of active 
Protein A was determined by breakthrough analysis (9). This assay 
technique measures only the active Protein A ligands. The columns were 
packed by the upflow slurry technique at 3000 psi with a Micromeritics 
slurry packer (Norcross, PA) and a Haskell pneumatic pump (Deerfield, 
IL). 
PITC-labeled IgG was prepared by the method of The and Feltkamp 
(29,30,31) using FITC adsorbed on celite as the dye source. The celite 
was removed by filtration and the FITC-IgG conjugate purified on the 
preparative chromatographic system built in our lab and described in 
Figure 8. This system was composed of a Sephadex size exclusion 
column, with an exclusion limit of 20 kD, coupled with a DEAE cellulose 
anion exchange column. Initially, the excess label was separated from 
the IgG reagent on the Sephadex column with the green band of labeled 
Figure 8. Low performance preparative dual column chromatograph. 
This system was used to prepared FITC-lgG. Additionally, 
it may be used for other such applications. Either 
column may be used individually or in the switching 
mode as described. The entire system was assembled 
from simple components and built entirely in our lab. 
This chromatograph proved to be very durable in over 
one year of use 
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IgG eluting at the void volume. Unreacted IgG was removed from the 
conjugated IgG with a salt gradient on the DEAE column. Column 
effluent was monitored for the fluorescein label at 495 nm with a 
Beckman DU spectrophotometer equipped with a flow cell and for total 
IgG protein with the Altex detector. 
The eluent was collected in five mL fractions and the degree of 
FITC labeling of the IgG molecule determined using the nomogram of The 
and Feltkamp (30). Typical values of the degree of labeling were 1.8 
to 4.5 dye labels per IgG molecule. The fractions containing the IgG 
conjugate were pooled to obtain a sufficient quantity for experimental 
use. After pooling, typical values obtained for IgG concentration were 
0.3 mg IgG/mL, with a degree of labeling of.three. 
Acquisition of the Peak Decay Elution Profile 
The experimental generation of a PD profile with the chromato­
graphic system described in Figure 6 was a multistep procedure. 
Initially, the immobilized Protein A was saturated with PITC-IgG by 
recycling this solution through the column. A small amount of the 
FITC-IgG reagent was required to saturate the column; this allowed the 
FITC-IgG solution to be reused several times. The excess FITC-IgG was 
then washed from the column with pH 7 buffer until a stable fluorescent 
baseline was obtained. The flow rate of this washing buffer and that 
of the strong eluent from the Rainin pump, either an IgG solution or.pH 
3 buffer, were then matched. The switching valve was activated and the 
strong eluent applied to the column. This initiated the computer data 
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acquisition and the output of the DPC-2 was monitored for approximately 
two half-lives of the decay process. While the PD profile was eluting 
from the column, the ternary chromatograph eluent was changed from the 
pH 7 buffer to the pH 3 buffer. After the PD profile had been 
collected, the valve was returned to the initial position and all of 
the retained IgG was flushed from the Protein A column. When the 
baseline stabilized, the ternary system was returned to the pH 7 buffer 
and the Protein A column re-equilibrated. During this re-equili­
bration, the Rainin pump was restarted and, when completed, the valve 
again actuated so that the strong eluent once again saturated the 
column. At this point a sufficient amount of data was collected to 
describe the strong eluent baseline and data collection stopped. 
Finally, the column was flushed with the pH 3 buffer to again remove 
all of the IgG from the column. The column was then re-equilibrated 
with pH 7 buffer and the system was again ready to repeat the sequence. 
An example of the data obtained with the procedure is presented in 
Figure 9A. 
Calculation of the Peak Decay Rate 
The data acquisition procedure described above was designed to 
simplify the extraction of the PD kinetic rate from the experimental PD 
profile. The simplest treatment of first order kinetic data for 
extracting the rate is to linearize the data with a logarithmic trans­
formation (11). The kinetic rate is then expressed as the slope of 
this line. This treatment assumes that the reaction is complete or 
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that an infinite reaction time has passed and that the analytical 
signal at this time is measurable. Accurate linearization of the data 
requires that the infinite time signal be included in the mathematical 
treatment of the kinetic data. 
Often, the analytical signal at infinite time cannot be 
approximated experimentally. Data treatments have been described to 
allow for the estimation of kinetic rates where the sampling time is 
limited. Examples of such treatments are the Guggenheim (32) and 
Kezdy-Swinbourne (33,34) methods. Unfortunately, these data techniques 
amplify noise in the data. This limits the applicability of these 
methods when the detection limit of the instrument is approached by the 
enQieriment (35) . 
In addition to the mathematical treatments of the data, the PD 
chromatographic model allows for the experimental simulation of the 
infinite time signal. The initial step in the data reduction for the 
experimental approximation is the determination of the infinite time 
baseline value. Using Figure 9a as an example, this would be the 
region from 902 to 1068 sec obtained when the IgG solution was 
reapplied to the column after the initial flushing. The baseline 
signal was averaged over this region. The exponential decay region was 
then selected as 72 to 308 sec and the baseline value subtracted from 
this decay region to correct for the infinite time instrument component 
of the signal. These corrected data were then linearized by log 
transformation, as demonstrated in Figure 9b. The linear portion of 
this plot was then selected as 84 to 248 sec and the best fit line 
137 
calculated with the linear least-squares technique. The slope of this 
line is taken as the best estimate of the apparent PD rate. 
After using each of the techniques, it was decided that the 
experimental infinite time approximation and linearization of the data 
was the most reproducible of the data reduction methods used. All of 
the data presented have been obtained using this method. 
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RESULTS AND DISCUSSION 
Characterization of the Affinity Support 
The properties of the affinity support are important for the 
design of the actual experiment. The coverage of Protein A ligand was 
selected to be 0.5 mg Protein A/g silica. This coverage was chosen 
because a capacity factor of 1.15 could be predicted for a 0.5 mg/mL 
IgG inhibitor solution and thus minimize consumption of the inhibitor 
reagent. The support actually prepared for this work had a total 
Protein A coverage of 0.61 mg protein/g silica. Using a breakthrough 
assay technique (9), an active ligand density of 2.9 x 10~® mole 
protein A/L was found. This represents an activity of 1.5 mg IgG/mg 
Protein A or about a 20% retention of activity by the immobilized 
ligand. When compared with similar preparations of immobilized Protein 
A (9), this represents a typical retention of activity. This support 
was calculated to produce a k' of 0.94 with an IgG inhibitor solution 
of 0.5 mg/mL. When this material was packed in the 4.2 mm x 25 mm 
column, a total column loading of 2 x 10® moles of IgG could be 
e:q>ected to be retained by the column. 
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Determination of Chromatographic Parameters 
Biospecific Elution 
The experimental determination of the residence time and 
inhibitor concentrations required to produce the PD effect was 
required. It was necessary to fix either the t^ or inhibitor concen­
tration at a value sufficient to produce the PD effect and vary the 
other parameter over the region where the PD assumptions become valid. 
This "break" region where the PD rate becomes independent of the 
experimental parameter demonstrates that the assumptions have been met. 
As the affinity support was well defined experimentally, it was decided 
to initially estimate the necessary inhibitor concentration and then to 
experimentally determine the residence time required to produce the PD 
effect. 
The estimation of the experimental parameters with the computer 
simulations was complicated by the varying kinetic and thermodynamic 
data available for the Protein A-IgG system. The initial step in this 
process was the estimation of the k_i/k_3 rate ratio. The diffusion 
kinetic rate k_i was calculated by substituting values of 4.7 x 10"? 
cm^/sec and 0.1 for the diffusion coefficient and tortuosity, respec­
tively, into Eq. 2. A k_j^ value of 2.4 sec"! resulted. Values of k_3 
for both the primary and secondary adsorptions can be determined from 
independent work. Under low IgG conditions the k_3 was estimated to be 
2.3 X lOrS sec"l and with high IgG concentrations the k_3 was estimated 
as 5.5 X 10"4 sec"^ as described by Mayhre (6) and O'Keefe (5), 
respectively. 
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Alternatively, k_3 may be estimated with kg and affinity constant 
(K3) considerations. The association rate of the Protein A IgG complex 
(kg) has been estimated as 2.4 x 10^ M~^ sec"! using split peak 
affinity chromatography with immobilized Protein A (9). Using these 
data, Protein A IgG complex dissociation rates (k_3) were estimated for 
the primary and secondary adsorptions as 6.1 x 10"^ sec"^ and 3.75 x 
10""2 sec"!, respectively. 
Each of these dissociation (k.g) rates and conditions under which 
they were generated results in a unique set of parameters required to 
produce the PD effect. These are summarized in Table I. The 
estimation of inhibitor concentration was done with Figure 4. The most 
rigorous inhibitor concentration requirement was k* = 1 with a 
normalized slope of 0.9. This should be capable of demonstrating the 
PD effect for each of the possible experimental models presented in 
Table I. 
The estimation of the flow rate required to produce the PD effect 
is shown with Figure 5. This estimation is complicated because the 
appropriate subplot must be determined. For the high performance 
support used in this work, Vp was equal to Vg. Unfortunately, this 
series of plots does not extend to the 10,000 range estimated for the 
Protein A IgG rate ratio. Extrapolation of the trends in Figures 4 and 
5 would produce a plot similar in form to Figure 5c with the k' = 1 
line shifted to approximately the position of the k' = 0.1 line and the 
k' = 0.01 line for rate ratios of 100 and 1000, respectively. Using 
this approach, it was estimated that values of tj^ x k_3 < 0.3, 
corresponding to residence times of<480 sec, would be appropriate to 
141 
produce the PD effect with the primary adsorption. Similar treatment 
for the secondary adsorption indicates that a maximum residence time of 
eight seconds would be required, as shown in Table I. 
The initial set of experimental studies involved the determination 
of the flow rates required to meet the assumptions of the PD model. 
For this work the long column was used with flow rates from 0.05 to 
0.75 mL/min and an inhibitor concentration of 0.6 mg IgG/mL, corre­
sponding to column residence times of 278 to 18.5 sec and a k' of 0.8, 
respectively. 
An example of. the data obtained with the biospecific elution is 
presented in Figure 9. The various regions of the data collection 
process are noted. The linearized form of the data from which the 
"apparent" PD rate was determined is also presented. 
The results of this study are presented in Figure 10 where the 
measured PD rate is plotted against the flow rate. The measured PD 
rate decreased with flow rates below 0.5 mL/min and was independent of 
flow rate above this value. The plateauing at a flow rate above 0.5 
mL/min indicates that column residence times smaller than 27.5 sec were 
required to meet the PD model assumptions. This value is intermediate 
with respect to the column residence time of 480 sec and 8 sec 
predicted for the primary and secondary adsorptions, respectively. 
This discrepancy arises from an error in the estimation of the actual 
k_3 rate. The best estimate of the k_3 rate for primary adsorption was 
6 X 10"^ sec'l, while the experimentally measured values presented in 
Figure 10 are closer to 8 x 10"^ sec"^. Using this experimental k_3 
rate, a rate ratio of 300 was calculated. If the experimental rate 
Figure 9. Exançle chromatogram of biospecific elution of analyte 
IgG with inhibitor IgG. An eluent flow rate of 0.6 mL/min 
and an IgG inhibitor concentration of 0.6 mg IgG/mL were 
used. The peak decay region was selected as 72-308 sec 
and logarithmically transformed as shown in B). The 
region from 84-248 sec was selected as the best linear 
portion and the k_3 calculated as 0.0068 sec"^ with a 
regression coefficient of 0.96 
143 
A )  
721 
• 8 4  
1" 
G 
N 
A 
L 
2 4 8  
0 8 902 1068 
0 
B) 
310 6 2 0  9 3  0  
S E C 0 N D S 
L 
N 
G 
N 
A 
L 24 8 
'40 
4-
3  0  8  
10 0 200 
S  E  C  0  N  D  S  
3 0 0  
Figure 10. Plot of the experimental PD rate versus eluted flow 
rate used in obtaining the PD profile. All data were , 
taken at 25°C with the 25 mm column and an inhibitor 
concentration of 0.6 mg IgG/mL. Error bars are ± one 
standard deviation 
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constant were used to estimate the residence time, assuming the same k' 
approximation as above, a residence time of 37.5 sec is predicted by 
Figure 5. This value is close to the experimental value of 27.5 sec 
and demonstrates the ability of the computer simulation to approximate 
the residence time requirements. The original error was in the 
estimation of the k_3 rate and affirms our assumption regarding rate 
ratio and k' conditions used in interpreting Figure 5c. This also 
illustrates the importance of the estimation of the kinetic rate in the 
prediction of the experimental parameters needed to produce the PD 
effect. The initial region of the decay was used to calculate the PD 
kinetic rate. At later times curvature was observed in the linearized 
plot and is indicative of heterogeneities in the desorptive sites (8). 
%on completion of the flow rate study it is necessary to 
determine the validity of the inhibitor concentration used in this 
study. The internal consistency must be verified by comparing the 
inhibitor concentration used for the flow rate study with the plateau 
values obtained with the inhibitor concentration study. If the initial 
inhibitor concentration was found to be out of the plateau region, it 
would be necessary to repeat the flow rate study at a higher inhibitor 
concentration. For this work IgG concentrations between 0.05 and 1.0 
mg/mL corresponding to k' values of 9.2 to 0.47 were studied at a flow 
rate of 0.6 mL/min (tm = 23 sec). The apparent PD rates were 
determined and are plotted versus IgG concentration in Figure 11. 
The break region is shown in Figure 11 to be about 0.5 mg/ml 
(k' = 0.94), with measured PD rates being independent of inhibitor 
Figure 11. Plot of the experimental Peak Decay kinetic rate versus 
the inhibitor concentration used in obtaining the rate. 
All data were taken at 25°C with the 25 mm column and a 
flow rate of 0.6 mL/min. Error bars are ± one standard 
deviation 
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concentration above this value and decreasing at our inhibitor 
concentration. The kinetic rate measured in the plateau region was 8.2 
X 10"3 sec"!, which is consistent with the flow rate study. The IgG 
inhibitor concentration of 0.6 mg/mL predicted with the simulations and 
used in the flow rate study was thus found to be sufficient to meet the 
PD assumptions. Thus, the experiments were found to be internally 
consistent. 
The k_3 value of 0.008 sec"! was faster than both the primary 
adsorption (k.g) calculated rate of 6 x lOT^ gee"! and the experimental 
k_3 rate of 5.5 x 10"^ sec"^ (5). This discrepancy in the experimental 
k_3 values may be an artifact of the experimental design. This latter 
high IgG work was performed in free solution and the effect of diffu­
sion was not controlled. 
Biospecific elution may also be studied with electrophoretic 
desorption where once the analyte has dissociated, the electric field 
moves the analyte through the support (36). The dissociation of the 
Protein A IgG affinity complex has also been studied with electro­
phoretic desorption of IgG from the support by Haff (37). A k_3 rate 
of 9.11 X 10"5 sec'l was estimated from this work. Unfortunately, this 
work was performed with no IgG inhibitor and is thus indicative of the 
primary adsorption. Haffs desorption rate is, however, in good agree­
ment with the k_3 value of 2.3 x 10"^ sec"^ obtained by Mayhre and 
Kronvall (6). Consideration of these results indicates that the 
secondary adsorption (high IgG) has a faster k_3 rate than the primary 
adsorption by about one order of magnitude. The selection of the 
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initial decay region further emphasizes this faster secondary k_3 value 
as any slower heterogeneous sites are expected to affect the latter 
regions of PD profile (8). This further corroborates the presence of 
two cooperative adsorption sites for IgG on Protein A as has been 
previously reported (20). 
Nonspecific Elution 
The concentration of urea and ammonium thiocyanate has been shown 
by Chervenka (38) and Eveleigh and Levy (39) to directly affect 
biocomplex dissociation kinetic rates. The pH of the eluent has also 
been shown to affect the dissociation of the IgG-Protein A complex with 
the selective elution of the huiiian IgG subclasses on immobilized 
Protein A columns (40,41). These studies demonstrate the importance of 
quantitative study of denaturing dissociation processes. 
Rather than determining the effect of strong eluent pH on the dis­
sociation rate, the step change of eluent pH from seven to three was 
selected for the denaturing elution studies. Once this elution scheme 
was selected, the column residence time could be estimated with Figure 
5c by assuming a k' of 0.01 for the strong eluent. This permits t^ x 
k_3 values as large as 1 to be valid for the estimation of the PD 
kinetic rates. A value of 2.4 sec"^ was chosen for the k_3 dissocia­
tion rate. This is the fastest process that can be determined by the 
PD method with diffusion as the limiting case, and faster flow rates 
would be futile. With these assumptions, a residence time of 0.42 sec 
was calculated for pH elution. To achieve this, small columns and 
rapid flow rates were required. 
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Similar flow rate experiments were thus undertaken for the 
estimation of the pH elution PD kinetic rate. Rather than the rigorous 
estimation of column dimensions, the smallest available column was used 
for this study. This column permitted a maximum of cross-sectional 
area with a minimum of column length, producing the lowest backpressure 
at a given flow rate. With this design it was possible to simply 
increase the flow rate until the plateau region was observed. 
The kinetic rate of the pH dissociation technique was much faster 
than the biospecific dissociation kinetic rate. The pH elution profile 
decayed to the baseline or the infinite time approximation in less than 
one min. This eliminated the need to experimentally simulate the 
infinite time situation. Data collection was stopped after the base­
line had stabilized, simplifying both data collection and evaluation. 
An example of the data obtained with the nonspecific elution technique 
is presented in Figure 12 along with the linearized form from which the 
apparent kinetic rate was determined. 
The effect of flow rate on the measured peak decay rate with non­
specific elution was determined. The plot of flow rate versus the 
"apparent" kinetic rate is presented in Figure 13 and demonstrates the 
plateau effect at high flow rates. The kinetic rate obtained for this 
region was 1.2 sec"^, or approximately a hundredfold increase in the 
apparent PD kinetic rate with pH elution. As expected, the plateau 
effect occurred at much higher flow rates than observed with the 
biospecific elution. Flow rates above 4.0 mL/min or, for the column 
used, residence times below 0.89 sec were required to demonstrate the 
Figure 12. Example chromatograms of pH elution of analyte IgG from 
the 6.25 mm column. For this study an eluent flow rate 
of 2.0 mL/min was used. The baseline region was taken 
as 29.1-33.0 sec and the peak decay region was selected 
as 19.5-26.8 sec and logarithmically transformed. The 
best fit linear region of 21.0-24.2 sec was chosen and 
the slope determined. A k_3 rate of 0.54 sec_i was 
calculated from a line with a regression coefficient 
of 0.99 
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PD effect with pH elution. The computer simulation had indicated a 
residence time of 0.42 sec, which is in reasonable agreement with the 
experimental data. 
Unfortunately, this work demonstrates one of the shortfalls of the 
PD model. As illustrated in Figure 4, the PD model fails to accurately 
estimate either k_3 or k_i if 0.1 < k_i/k_3 < 10. The k_i value has 
been calculated to be 2.4 sec"^ and, with substitution of the experi­
mentally determined k.^, a rate ratio of 1.9 can be estimated. This 
was only a rough estimate of the rate ratio, as 2.4 was only an 
estimate of k.^ . 
It is possible to infer that the denaturation rate constant was 
not significantly different from the diffusion-limited rate constant. 
Another possibility is that the nonspecific elution actually is 
diffusion-limited, with a k_i rate of 1.2 sec~^, and the estimated 
diffusion rate constant (k_i) was a poor estimate with much faster 
denaturation/dissociation kinetics. The data obtained with these 
techniques are not capable of differentiating these cases. 
The kinetic rate studies presented above indicate significant 
differences between the biospecific elution and nonspecific elution 
techniques. These results are not surprising in that these elution 
schemes proceed along fundamentally different mechanisms. With the 
biospecific elution schemes the tertiary and quaternary structures are 
preserved and dissociation of the biocomplex occurs through inter­
actions of the native molecule. The various nonspecific elution 
schemes operate under fundamentally different mechanisms at the 
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molecular level. Reagents such as urea and guanidinium HCl break the 
hydrogen bonds responsible for complex formation so that denaturation 
induces the dissociation (12). Chaotropic salts affect the water 
structure, although they do not denature the affinity complex. Rather, 
these elution techniques undergo native dissociation whereupon the 
chaotropic salts eliminate the reformation processes. This unique 
property is caused by the tight association of the biocomplex which 
precludes the reagent from reaching the binding site until native 
dissociation occurs (12). Other examples of denaturing elution 
techniques are extremes of pH which affect the protonation of the 
protein and, thus, the hydrogen bonds forming the complex; the addition 
of organic solvent such as ethylene glycol to affect the hydrophobic 
interactions; and the use of anionic salts such as citrate affect salt 
bridge formation (21). These examples demonstrate the differences in 
the denaturing desorption techniques and the importance of the 
selection of desorption method in the design of the experiment. 
Kinetic analysis of the desorption phenomenon is required to delineate 
the mechanism of the dissociation. 
An example of this type of study was illustrated with the pH 
elution of IgG. Rather than focusing on the dissociation or diffusion 
limitation of IgG desorption with low pH elution, the relative magni­
tude of the native and denatured dissociation rates is important. 
These values indicate that the pH elution is similar to the H bond 
breaking dissociation rather than the chaotropic dissociation of IgG. 
Had the opposite been true the denaturing dissociation rate would have 
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been several orders of magnitude slower and similar to the biospecific 
elution PD rate. 
Determination of Activation Parameters 
A classical technique for comparing various kinetic processes is 
the comparison of the activation parameters of the processes. The 
estimation of these parameters involves the determination of kinetic 
rates over a range of temperatures and calculation of the enthalpy 
(AH*) and entropy (AS*) of activation by various plotting techniques 
(11). The PD rate constant for the Protein A-IgG complex was estimated 
over a temperature range of 5-25°C. Other experimental parameters were 
used as determined above for the biospecific and pH elution techniques. 
The "apparent" PD kinetic rate was determined in triplicate for each of 
the tenperatures studied. 
The kinetic data obtained at the various temperatures are plotted 
as In (k_3) versus 1/T(°K) and are presented in Figures 14 and 15 for 
the biospecific and pH elution, respectively. From these plots, the 
AH* and As* parameters were calculated to be 14 ± 6 Kcal/mol and 
-38 ±21 cal/mol "K for biospecific elution, and 4.6 ± .3 Kcal/mol 
and -16 ± 1 cal/mol °K for pH elution. Comparison of these values 
indicates that the biospecific elution process has larger energy 
requirements. 
Of more significance than the magnitude of the quantitative 
results was the qualitative shape of the activation energy plots. The 
pH elution plot appears linear over the temperature range studied, 
Figure 14. Arrhenius activation energy plot for biospecific elution. 
All ohromatograms were obtained at a flow rate of 
0.6 mL/min and a concentration of 0.6 mg IgG/mL. Error 
bars are ± one standard deviation 
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while the biospecific elution plot exhibits a downward curvature, 
indicative of a more complex interaction. This curvature could arise 
from the more complex biochemical dissociation or as a result of the 
experimental method. 
For the initial evaluation of these data, the complex behavior of 
the biospecific elution was assumed to arise from the native dissocia­
tion process. From the magnitude of the dissociative (k-g) and 
diffusive (k_i) rates reported for the pH elution, it was not possible 
to determine whether the limiting case was diffusion- or dissociation-
controlled as was previously described. The activation data, however, 
indicate a simple mechanism for pH elution and could simply reflect the 
activation parameters for a diffusion-controlled process. Biocomplex 
dissociation control of the pH elution process would be expected to be 
a complex pattern as with the biospecific elution. The absence of this . 
complex behavior would support the diffusion control of the pH elution. 
Diffusion control of the IgG pH elution is also indicated by the 
magnitude of enthalpy value. A AH* value of 4 Kcal/mol has been 
reported for a kinetic process under diffusion control (42) due to the 
effect of temperature on aqueous solvent viscosity. 
Complicating this simple analysis of the activation parameters is 
work by O'Keefe and Bennett (5). As previously described, these 
workers studied the dissociation of the Protein A IgG complex with high 
IgG inhibitor concentrations. In addition to the determination of the 
dissociation rates, the effect of temperature on these rates was also 
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studied. These data permit the calculation of the dissociation activa­
tion parameter under conditions similar to the biospecific elution 
experiments. The activated complex plot of their work was linear from 
4-37°C with a correlation coefficient of 0.95. Values of AH* = 8.95 
Kcal/mol and AS* = -39.4 cal/mol were found. These results are well 
above the diffusion-limited case and demonstrate excellent linearity. 
These results indicate that the curvature of the PD biospecific 
dissociation plot of Figure 4 was a result of the experimental method 
and not a fundamental property of the biocomplex. Downward-curved 
activation energy plots are common for immobilized biochemicals (43). 
These curved plots are generally interpreted to imply the occurrence of 
a pore diffusion problem at the high end of the temperature range 
studied. Rather than a limitation of the PD method, this would be a 
problem with all porous support-immobilized biochemicals. 
Additionally, the immobilization processes can affect the AH*, 
complicating the comparisons of the results (1). 
It is also possible that the curvature of the activation energy 
plot was an artifact of the PD experimental method. The experimental 
process assumed that the conditions sufficient to produce the PD effect 
at 25°C were also sufficient to produce the effect at 5°C. This would 
require a similar dependence upon temperature for both the diffusion 
and dissociation phenomena. Both processes demonstrate approximately a 
doubling of rate with a 10°C temperature increase, as is typical with 
many reactions (11). If both rate processes were similarly affected by 
tenperature, the PD assumptions would apply over the entire temperature 
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range. It would be expected that any change in the temperature depen­
dence would be most obvious with the biospecific elution where the 
lower temperatures would slow the diffusion rate. This slowed diffu­
sion would result in longer within-pore residence times for dissociated 
analyte IgG. This increased time would enhance the possibility of a 
second adsorption and require higher IgG inhibitor concentrations to 
meet the PD assumptions. 
This proposed behavior is analogous to the failure of the PD 
method at rate ratios less than 1 as illustrated in Figure 4 and 
described earlier. When covering a range of temperatures with the PD 
method, it may be necessary to determine the flow rate and inhibitor 
concentration required to produce the.PD effect over the entire range 
of temperatures to be studied. 
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CONCLUSIONS 
The PD model has been theoretically described and a computer 
simulation of this model reviewed. A mid-affinity system, the Protein 
A IgG interaction, was used as a model to study the application of the 
PD model to the higher affinity biocomplexes. The application of the 
PD model to the fundamental studies of these biocomplexes has also been 
demonstrated. 
Critical to the success of obtaining the PD effect are the 
experimental conditions of the analyte residence time in the column and 
the inhibitor concentration. The use of the computer simulations to 
estimate the initial experimental conditions was described and can 
simplify the early design of the experiments. The simulation was 
proven to be capable of predicting the required experimental conditions 
to produce the PD effect. The use of the simulations in this manner 
can save much experimental effort. 
This work has demonstrated the need to accurately estimate the 
thermodynamic and kinetic data describing a system and the effect of 
the various situations on the predicted feasibility of the PD 
experiment. 
As immobilized biochemicals attain wider use, their fundamental 
properties will become increasingly important to experimental design. 
In addition to kinetic rates, factors such as the activation energy 
parameters can be used to describe thse systems. The PD model has been 
shown to be suitable for determining these kinetic and thermodynamic 
parameters for immobilized biochemicals. Unfortunately, ambiguities in 
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the data limit the quantitative evaluation of the biospecific and pH 
elution schemes studied. However, the differences demonstrated quali­
tatively that the two elution schemes were fundamentally different. 
The PD method has been demonstrated to be appropriate for the estima­
tion of the apparent dissociation rates as well as evaluation of the 
fundamental activation parameters allowing comparison of different 
elution techniques. 
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GENERAL SUMMARY 
The work described in this thesis involves many aspects of the 
design and use of High Performance Affinity Chromatography. HPAC 
combines the speed, convenience and separation efficiency of HPLC with 
the selectivity of biological recognition. With affinity chromato­
graphic separations, the ligand is immobilized and may be easily 
reused, unlike other bioaffinity-based analytical methods such as 
immunoassay (11). An additional advantage of the HPAC technique is the 
automation of the analysis which is possible with available auto-
sampling and signal integration equipment. This approach could 
simplify many separation methods and lead to new methods for the study 
of biomolecular interactions (37). Both practical and theoretical 
aspects of HPAC were studied and the implications on the experimental 
design discussed. 
The quantitation of IgG from human serum with HPAC was demon­
strated in Section I. For this work the affinity adsorbent was Protein 
A from the S. aureus bacteria immobilized on diol-bonded silica using 
CDI. Sanple preparation was negligible, with only filtration of the 
serum performed. Small sample volumes, usually less than 10 uL of 
serum, were required for the analysis. The stability of the Protein A 
affinity ligand was excellent, with little loss of activity after 
several hundred analyses over a two year period. Analysis times were 
quite rapid, with a complete cycle of pre-equilibration, injection, 
elution of nonsorbed components, low pH elution of IgG and re-
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equilibration in pH 7 buffer possible in four minutes. The diol 
bonding minimized nonspecific adsorption of protein, and column 
plugging was not observed over this use. 
Limitations of an affinity separation are also evident in this 
HPAC method for IgG. With this type of application, the affinity 
ligand must be very selective since the low pH buffer will elute all of 
the retained species as a single band. If the support retained 
multiple sample components, the purity of the analyte would be 
compromised (2). This is a problem with the use of Protein A as an 
affinity ligand. Protein A retains most IgG and some IgA and does not 
retain IgGS, IgM or some IgA. These binding anomalies ultimately limit 
the ability of the retained immunoglobulins to accurately profile the 
actual immunoglobulin concentration in serum. However, the HPAC method 
was shown to be of comparable accuracy to radial immunodiffusion for 
IgG analysis. This could result from the fortuitous correction for 
loss of IgGS with the retention of some IgA. 
In addition to this fundamental bioactivity limitation, the 
activity of the GDI immobilized Protein A ligand was low. In Sections 
II and III the activity of immobilized Protein A was reported as 10% 
and 20% for GDI and Schiff's base immobilized Protein A, respectively. 
Not only was the binding activity of Protein A for IgG affected by the 
immobilization method, the kinetics of the adsorption process have been 
shown to be affected as well. In a study by Hage, the adsorption 
kinetics of CDI-immobilized Protein A were shown to be much slower than 
those of the Schiff's base-immobilized Protein A using Split Peak 
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affinity chromatography (24). The slower IgG adsorption kinetic rate 
of CDI-Protein A requires longer column residence times for the IgG 
analyte to fully bind with the ligand. Thus, CDI-Protein A is 
unsuitable for very small column dimensions, as have been used with 
Schiff's base Protein A (33). This latter case of a kinetic limitation 
illustrates a specific restriction of the immobilization chemistry and 
column dimensions for a particular situation as opposed to the 
fundamental specificity limitations described above. These latter 
problems may be minimized by proper design of the experiment. 
The immobilization of various ligands on diol-bonded high 
performance silica supports using the l,l'-carbonyldiimidazole reagent 
was studied in Section II. This GDI immobilization chemistry was used 
to attach protein macromolecular ligands and glucosamine to diol-
bonded silica supports. This reagent was selected because of the non-
ionic and stable urethane linkage through which the ligand is held to 
the solid support (33,65-67). 
To fully optimize the yield of immobilized ligand, both the 
activation of the support and the actual coupling of the ligand were 
shown to be important. The activation studies reported in Section II 
represent dramatic increases in the yield of the imidazole carbonate 
reactive intermediate. It was found that longer GDI activation 
reaction times and sonication were responsible for this increase. With 
these synthetic techniques it was possible to approach monolayer 
coverage of imidazole carbonate active intermediate sites on the diol 
support. The ability to control the degree of support activation was 
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also demonstrated with the GDI reagent. Unfortunately, proteins must 
be kept in aqueous solution and the imidazole carbonate active site is 
subject to rapid hydrolysis in aqueous solution. Previous workers had 
observed this hydrolysis and stopped the ligand coupling reaction after 
only a few hours (66,68,69). This was further studied in Section II 
and evidence for two populations of active sites presented. Approxi­
mately 90% of the active sites were hydrolyzed in several minutes of 
exposure to aqueous neutral buffers, but the remaining sites were 
stable for several days. Thus, the yield of GDI immobilized ligand was 
easily increased with longer reaction times. 
Other factors important for the immobilization of proteins in high 
yield were determined. The pH of the ligand coupling buffer was found 
to be a factor in the yield of immobilized protein ligand. Neutral and 
slightly acidic (pH 7-4) buffers were found to be capable of 
immobilizing protein ligands in high yield. The maximal yield of 
immobilized protein was found to be at approximately the isoelectric 
point of the protein. However, the optimal coupling pH for maximal 
yield must be determined empirically for each protein ligand. Once 
these coupling reaction parameters were described, it was possible to 
reproducibly prepare immobilized protein supports. This was 
demonstrated specifically with BSA, where a relative standard deviation 
of 13% was found with repetitive immobilization experiments. Where 
required, very high yields of immobilized proteins are possible. As 
was shown in Section II with the 10% by weight coverage of IgG on diol-
bonded silica. 
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The preparation of a highly active ligand is more important than 
just immobilizing a high yield of a low activity ligand. The effect of 
immobilization conditions on the activity of the ligand was also inves­
tigated in Section II. As the coupling solution pH was changed, the 
population of neutral amines capable of binding protein also changed. 
This effect may then affect the orientation of the immobilized protein 
ligand and thus the activity of the protein ligand (8). Studies were 
undertaken to demonstrate the effect of solution pH on the activity of 
the immobilized protein. The results were unpredictable, though 
differences were observed, illustrating the importance of optimizing 
the immobilization conditions for each protein ligand immobilized with 
a given immobilization chemistry. 
Many chromatographic techniques require the preparation of 
suppports of a known and reproducible ligand density. Examples are ion 
chromatography, ion-exchange chromatography, and hydrophobic inter­
action chromatography. The importance of ligand density to the ion-
exchange chromatographic behavior of proteins has been demonstrated by 
Landgrebe, Wu and Walters (70). These workers have reported the 
"ester-amide" synthesis technique for the preparation of supports with 
a reproducible and controllable degree of activation. Unfortunately, 
the preparation of activated supports using this chemistry is a 
rigorous procedure. 
An interesting application of the GDI immobilization chemistry 
would be the preparation of supports of various ligand densities for 
these techniques. In Section II it was shown that the imidazole 
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carbonate reactive intermediate could be reproducibly prepared over a 
wide range of active site densities. The inability to control final 
ligand density with the active site coverage arose from the hydrolysis 
of the active site in aqueous buffers. The immobilization of the 
ligands used with these relatively nonspecific types of chromatography 
would be amenable to nonaqueous reaction conditions. The reactive 
site hydrolysis would then not be a factor, so that final ligand 
density could be controlled through the activation. Other advantages 
of using GDI for this type of support preparation would be the inert­
ness, stability and ease of preparation inherent in the GDI chemistry. 
In the final section, the use of HPAC methods, specifically the 
Peak Decay model, for the determination of fundamental biocomplex 
dissociation kinetics was demonstrated. The Peak Decay model and a 
computer-simulation of this model were described in Section III. The 
simulation was used to estimate the suitability of the Peak Decay 
method to the study of the Protein A-IgG affinity system, as well as 
for the estimation of the chromatographic parameters required to 
produce the Peak Decay effect. 
In the Peak Decay model all adsorptive processes are minimized 
through the use of high concentrations of competitive inhibitor and 
rapid eluent flow rates. Once the analyte dissociates, it should elute 
from the column without further interactions. The validity of using 
the Peak Decay model to describe the dissociation of analyte from the 
affinity support was demonstrated both qualitatively and quantitatively 
in Section III. Both the shape of the actual Peak Decay elution 
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profile (Figure III-9) and the shape of inhibitor concentration and 
residence time plots (Figures III-IO and III-ll) were as predicted with 
the computer simulation. 
Using sufficient chromatographic parameters to meet the Peak Decay 
assumptions, an experimental Peak Decay kinetic rate (k_3) of 0.008 
sec"l was observed. The parameters required to produce accurate 
desorption rate values using the Peak Decay effect for the Protein A-
IgG affinity system using experimentally determined rate values were 
estimated with the computer-simulation and were found to be a column 
residence time of 37 sec and an inhibitor concentration of k' equiva­
lent to 0.94. For the support and column chosen this represented an 
inhibitor concentration of 0.5 mg IgG/mL and a flow rate of 0.540 
mL/min. The actual values of these parameters required to produce 
plateau values of the desorption rate constants from the Peak Decay 
effect were then experimentally determined. Values of 0.6 mL/min and 
0.5 mg IgG/mL were required. Expressed as the reduced parameters, 
these represented a residence time of 27 sec and a k' = 0.94. This 
indicated that the computer simulation was appropriate for the estima­
tion of the chromatographic parameters required to produce the Peak 
Decay effect. Similarly, the appropriateness of the Peak Decay model 
has been shown for the Con-A sugar system (64). 
The study of Protein A-IgG biocomplex dissociation with the Peak 
Decay model demonstrates many fundamental properties of the Protein A-
IgG interaction. As was described in Section III, evidence for a 
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negative cooperativity between the two adsorption sites has been shown 
(62). The results of the Peak Decay experiments clearly favor the 
negative cooperativity argument since the other models do not fit with 
the experimental results. 
The magnitude of the Protein A-IgG native dissociation rate (k_3) 
(0.008 sec"!) provides insight into the biocomplex interaction. The 
half-life for this first-order dissociation process is 87 sec. Rather 
than the very stable biocomplex imagined when the affinity constant of 
4 X 10® M~^ is considered, the Protein A-IgG interaction is a dynamic 
process of association and dissociation events. This relatively rapid 
turnover would be significant for competitive binding assay techniques. 
This indicates that shorter incubation times (minutes rather than 
hours) could be suitable for competitive binding assays, as has been 
observed by de Alwis and Wilson (71). 
Studies of low pH nonspecific elution were also performed. A 
diffusion-limited dissociation rate of 1.2 sec"^ was found for this 
type of IgG elution from Protein A supports. This was much faster than 
the 0.008 sec"! found for the native dissociation of the Protein A-IgG 
complex. The Peak Decay effect was also shown to be capable of 
determining the activation parameters for the dissociation of the 
affinity complex with both the naturing and denaturing elution 
techniques. The Peak Decay method should be useful for studying the 
various types of nonspecific elution for comparison and selection of 
the optimum elution technique for a particular affinity system. The 
Peak Decay method should also provide information on the fundamental 
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denaturation/dissociatlon processes as was described in Section III. 
Many ai^ects of High Performance Affinity Chromatography have been 
studied. An actual application was described in Section I. This work 
demonstrated the advantages of HPAC for the quantitation of biological 
substances. The development of an affinity separation requires the 
immobilization of the affinity ligand. This was studied in Section II 
with techniques for the optimization of immobilized ligand yield and 
activity. Once the affinity support is prepared and packed in the 
column, the separation is performed. Assuming analyte retention, the 
method of elution is important. The eluent strength should suffice to 
elute the analyte yet not damage the activity of the ligand. This was 
addressed in Section III where methods for the optimization of the 
elution technique were described using the Peak Decay kinetic model. 
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